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The feto-maternal interface is vital to promote growth and development of the placenta while 
maintaining tolerance and surveillance through the immune system. Pathogens are detected 
through pattern recognition receptors, which have a key role in the innate recognition by 
transducing signals from pathogen-associated molecular patterns. Lipopolysaccharide, a PAMP 
of Gram-negative bacterium, is recognized by the Toll-like receptor. Cluster of differentiation 
(CD) 14 and macrophage receptor with collagenous structure (MARCO) are key players in 
innate recognition. The hypothesis derived from the above is that MARCO might be expressed 
on trophoblast cells and plays a valuable role in association with CD14. The interaction of CD14 
and MARCO was explored with the use of confocal microscopy which showed physical 
associations, most likely contributing to their function at the feto-maternal interface. Trophoblast 
responses to LPS indicated a significant role in regulating the expression of CD14 and MARCO 
and NF-κB translocation and activation. It was also hypothesized a correlation between the 
down-regulation of Myoferlin and vascular endothelial growth factor (VEGF), and the decreased 
cell proliferation of trophoblast cells upon treatment with LPS. Myoferlin and VEGF 
quantification estimated by flow cytometry and western blotting showed significant decrease in 
LPS treated JEG-3 cells in time and dose dependent manner. The cell proliferation assay 
revealed a significant decrease in trophoblast cell growth of LPS treatment suggesting it is 
associated with the decrease of Myoferlin of which the expression is reported to be correlated 
with VEGF. These data suggest that CD14 and MARCO can be modulated and thus might 
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Chapter 1  
Introduction 
1.1 Immune system 
 
The innate immune system is a subsystem of the overall immune system that implements early 
host defence against invading pathogens through its ability to differentiate between the self and 
non-self. At the maternal-fetal interface, innate immunity affords tolerance of the allogenic fetus, 
whilst simultaneously maintaining host defence against a diverse array of possible pathogens 
(Koga et al., 2010). Equilibrium must be maintained between both of these elements in order to 
promote growth and development of the placenta potentially, an imbalance can severely hinder 
pregnancy progression, by provoking clinical complications, many of which are caused by 
intrauterine infections. For this reason innate immunity is the dominate form of immune defence 
at the maternal-fetal interface. Aside from common immune cells, such as the macrophages and 
natural killer (NT) killer cells, placental cells, particularly trophoblast cells, have a role in the 
immune response (Abrahams and Mor, 2005).  
1.2 Placentation 
 
A healthy human placenta, which is regarded as a vital organ, is the deciding factor of a human 
pregnancy’s success. The success of its development is integral in a human pregnancy. The 
process of pregnancy begins with the successful fertilization which is then implanted in the 
fallopian tube at the ovum. The fertilized zygote, which is surrounded by the zona pellucid a, 
then swiftly splits and divides consequently into 2-cell, 4-cell, 8-cell and 16-cell stages (morula). 
The morula has 32-cell stage divisions and it also comprises of two layers – inner and outer – of 
cells, which consequently contribute in forming the blastocyst. Subsequently, there are further 




embryo which then develops into a fetus. The outer layer of the cells, which are called 
trophoectoderm, contains cells that have the ability to create extra-embryonic structures, 










Figure 1.1.Implantation of the blastocyst and invasion of the uterine wall. 
An illustration of interactions between trophoblastic and endometrial cells, including angiogenic 









1.3 Feto-maternal interface 
 
It is postulated that the placental trophoblast cells has a significant role in immune tolerance, 
since these are the only cells that have contact with maternal tissue (Yie, et. al., 2006). The 
properties of expressing endogenous retrovirus products, oncofetal proteins, imprinted genes and 
having relatively unmethylated DNA are the wide range of properties showcased by these cells 
(Trundley and Moffett, 2004). The presence of negatively charged, sialic acid-rich 
mucopolysaccharide layer, was originally thought to act as a physical barrier according to 
Medawar's first hypothesis but this was disproved since due to the fact that it could hinder the 
immunological cross-talk between the mother and the fetus. The expression of major 
histocompatiblity complex (MHC) molecules disproves Medawar's second hypothesis where it is 
stated that there is a lack of immunogenicity in the conceptus (Fernandez et al., 1999). 
Medawar's third hypothesis was also disproved since pregnancy can stimulate the mother’s 
immune system. 
The presence of either two types of helper T cell cytokines can also determine pregnancy 
outcome, type 2 helper T cells supports a normal pregnancy while type 1 can lead to spontaneous 
abortions (Raghupathy, 1997). Another vital function of the trophoblast cells is the transportation 
of maternal antibodies across the placenta and the removal of anti-fetal antibodies. These cells 
also secrete a plethora of pregnancy factors and hormones which minimises local immunity 








1.4 Pattern recognition receptors 
 
To detect pathogens, the innate immune system uses a variety of pattern recognition receptors 
(PRRs). PRRs are mainly expressed by antigen presenting cells and include Toll-like receptors 
(TLR), cluster of differentiation 14 (CD14) and scavenger receptors (Sankala et al., 2002). PRRs 
recognize and bind pathogen-associated molecular patterns (PAMP) molecules which result in an 
immunosurveillance response against invading pathogens (Koga et al., 2010). Pathogen-
associated structures, such as lipopolysaccharide (LPS), are recognized by PRRs and have the 
ability to stimulate the innate immune system. LPS is present in the outer membrane of Gram-
negative bacteria and is a very effective activator of immune responses (Sankala et al., 2002). In 
the present study, emphasis will be placed on CD14 and macrophage receptor with collagenous 
structure (MARCO) that play a valuable role in immune response through first-hand surveillance 
of pathogens (Abrahams &Mor, 2005).   
Emerging evidence indicates that trophoblast cells have the capacity to recognize and respond to 
pathogens by expressing TLRs (Abrahams & Mor, 2005). TLRs are a type of extracellular PRR, 
and have a primary role in the innate immune response in recognition of conserved molecules 
present on pathogens. Upon recognition of PAMPs which are unique to the pathogens, TLRs 
transduce signals which facilitate chemical reactions that lead to the synthesis of cytokines. The 
cytokines attract macrophages to the site of inflammation. Following ligation, the majority of 
TLRs induce activation of NFκ-B and cytokine production in a myeloid differentiation factor 88 
(MyD88)-dependent manner. The mode of expression and regulation of TLRs during pregnancy 
are unknown, as is their functional activity during pregnancy. Further studies of TLRs at the 
maternal-fetal interface will aid in understanding the mechanism that maintains the balance 




CD14 is one of the components of the receptor complex which mediates LPS-induced signal 
transduction (Zanoni et al., 2011). CD14 is a 55 kDa glycoprotein which is initially processed in 
the endoplasmic reticulum and then expressed on the cell surface (Gegner et al., 1995). CD14 
plays a significant role in this potent immune response through the transfer of LPS to the TLR-4-
MD2 complex (Gangloff et al., 2005). 
MARCO has been suggested to play a role in antimicrobial defence, and the up-regulation of 
MARCO during bacterial infection in macrophages of the liver and spleen provides evidence for 
this concept (Arredouani et al., 2004). Thelen et al. (2010) reported that MARCO transcription 
and cell surface expression increased after bacterial binding ,indicating its significance in 
phagocytosis .The expression of MARCO is also stimulated upon bacterial infection or LPS 
injection (Sankala et al., 2002). 
In summary, PRR in trophoblast cells are speculated to be significant in innate immune defence, 
and may play a key role in the maternal innate immune system. Nevertheless, their role in fetal 
tolerance still remains undetermined. Further studies of TLR at the maternal-fetal interface will 
aid elucidation of the mechanism that maintains the balance between fetal tolerance and 
pathogen defence (Holmlund et al, 2002).  
1.5 Toll-like Receptors 
Toll-like receptors constitute a family of transmembrane innate immunity PRRs that mediate 
immunity by recognising and responding to microorganisms (Burrough et al., 2011). TLRs are 
expressed on various immune cells, including macrophages, dendritic cells and neutrophils, as 
well as non-immune cells such as endothelial cells, epithelial cells and fibroblasts (Burrough et 
al., 2011). In humans, the TLR family consists of more than 10 transmembrane proteins and each 




TLRs bear leucine-rich repeats in the extracellular domain which recognize PAMPs in bacteria, 
viruses, fungi and parasites. Ligation of TLRs initiates the production of proinflammatory 
cytokines and immunoregulatory molecules via a common intracellular signalling pathway 
(Lorne et al., 2010). MyD88, an essential adaptor protein in the IL-1R1 signalling pathway, is 
recruited by the TLR upon ligand recognition. TLR interaction with MyD88through the toll 
interleukin 1 domain results in activation of a kinase cascade, activating the NFκB pathway and 
resulting in an inflammatory response (Abrahams et al., 2005). 
TLR-4 are recognized to be significant receptors in immune responses against pathogens. TLR-4 
is significant for the recognition of Gram negative bacteria and is effective in responses to LPS 
(Holmlund et al., 2002). In addition to PAMPs, TLR-4 have the ability to bind  damage-
associated molecular patterns (DAMPs), such as heat-shock protein (Hsp) 60,  Hsp70,  Hsp90, 
high mobility group box protein 1, and fibrinogen (Mor 2008).  
TLR-4 induces activation of NFκ-B pathway and cytokine production in a MyD88-dependent 
manner. However TLR-4 can also signal in a MyD88-independent manner, through another 
adapter protein, Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF), which 
induces the expression of type I interferons (IFN) and IFN-inducible proteins, as shown in figure 







Figure 1.2:  Signalling by Toll-like receptors 
The MyD88-dependent pathway of TLR-4 induces synthesis of inflammatory cytokines .TLR-4 





1.6 Function of TLRs in the Placenta 
 
In the human placenta, all TLR members have been detected. Most are expressed in trophoblast 
cells. The expression of TLRs in trophoblast can differ according to gestational and differential 
stage (Mor 2008).  In first trimester placentae, TLR-2 and TLR-4 are expressed by villous 
cytotrophoblast and extravillous trophoblast cells, but not by syncytiotrophoblasts (Koga et al., 
2010). The absence of TLR expression in the syncytiotrophoblast is speculated to restrict the 
response by placental tissue to microbes that have broken through this layer.  Thus, the fetus is 
only threatened by pathogens if the TLR-negative syncytiotrophoblast layer is ruptured and the 
pathogen is able to enter through the decidual or placental villous compartments (Koga et al., 
2009).   
Ma et al., (2007) evaluated the expression of TLR-4 in third-trimester placentae. Most TLR-4 
expression is observed in syncytiotrophoblast and endothelial cells (Ma et al., 2007). 
First-trimester trophoblasts exhibit a moderate up-regulation of cytokines induced by ligation for 
TLR-4 with LPS (Koga et al., 2010).  
1.7 TLR-4 response and preterm labor 
 
TLR-4 is implicated in susceptibility to preterm delivery, as induced by Gram-negative bacteria.  
Within the context of TLR-4 signalling associated with preterm delivery,15-
hydroxyprostaglandin dehydrogenase expression, a prostaglandin-catabolizing enzyme present in 
fetal and maternal tissue, is down-regulated subsequent to the ligation of TLR-4 with LPS (Koga 
et al, 2009).  It has therefore been speculated that bacterially induced preterm labor is mediated 
by TLR-4 through down-regulation of degradation of prostaglandin. Systemic and local 
inflammatory responses subsequent to LPS regulation may be the cause of preterm labor (Koga 




The fetal death and decidual necrosis has been proven to be reduced by the TLR-4 antagonist. 
However, bacterial colonization in the placenta was not affected by this antagonist, confirming 
that TLR-4 antagonized has the ability to control the inflammatory response   (Abrahams et al., 
2005).  
1.8 Fetal Development 
 
TLR-4 activation in the fetus is speculated to be the cause of cerebral white matter damage, a 
significant problem affecting in preterm neonates. Contrarily, however, the TLR system is 
involved in protective effects against neonatal allergic diseases such as asthma (Koga et al., 
2010). 
Immunohistochemistry analysis of skin samples obtained from preterm delivered babies revealed 
the expression of TLR2 and TLR-4. Given also that following LPS exposure fetal monocytes 
secrete cytokines and chemokines, it can be stated that fetal cells can contribute to innate 
immune defence. 
1.9 TLR expression at the maternal–fetal interface in pregnancy disorders 
 
The expression of TLR-2 and TLR-4 in chorioamniotic membranes   at term and in preterm 
parturition has been reported to be associated with chorioamnionitis (CAM), a condition most 
often associated with prolonged labour. It has been shown that TLR2 and TLR-4 mRNA is 
significantly greater in chorioamniotic membranes from women at term with spontaneous labor 
in comparison to women not in labor. The expression of TLR2 in chorioamniotic membranes 
was significantly higher in CAM patients than in those without CAM. Additionally, in non-CAM 
preterm labor, TLR-2 expression was limited to the basal surface of amniotic epithelial cells.  In 
contrast, diffuse and strong positive staining of the entire cytoplasm of the epithelium was 




In contrast, high expression of TLR-4 in villous Hofbauer cells was observed in preterm 
placentae of patients with CAM, compared to expression levels in preterm placentae of patients 
without CAM, or term placentae of patients with or without CAM. Recently, TLR-4 has been 
found to be expressed in the basal membrane of the amniotic epithelium in CAM patients (Ref). 
It was presumed   that an infection may induce the translocation of TLR-4 from apical to basal 
membrane was induced by the infection. This might decrease the signalling of TLR-4 during 
early infection while maintaining the amniotic epithelium as a hostile environment to invasive 
bacteria (Kumasaki et al., 2004). 
Significantly higher TLR-4 expression in trophoblast was observed in women with preterm 
delivery associated with pre-eclampsia, in comparison to women with or without CAM-
associated preterm delivery. Furthermore, the presence of inflammatory cytokines indicated its 
ability to induce TLR-4 expression by the co-localization of TLR-4 with activated NF-kB, TNF-
α and M30 and it is suggested to enhance the response to TLR ligands (Koga et al., 2010). 
There has been recent interest in polymorphisms in TLR genes and their impact on pregnancy 
disorders. Such polymorphisms have been observed to be associated with impaired function of 
TLR molecules and an enhanced susceptibility to infections. Recent experimental studies have 
revealed that susceptibility to early-onset preeclampsia is affected by TLR-4 polymorphisms, 
which enhanced liver enzymes and low platelets syndrome. Furthermore, the presence of the 
TLR2 Arg753Gln polymorphism and two TLR-4 SNPs (Asp299Gly and Thr399Ile) was 
associated with normal pregnancy controls. These observations indicate the significance of TLR 
in preeclampsia and also its involvement in various pregnancy disorders (Mor 2008). 
Despite their independent involvement inimmunoregulatory responses, synergy between TLR-2 
and TLR-4 has been proposed, wherein consistent signalling is reliant upon the co-stimulation of 




between LPS, the ligand for TLR-4, and muramyl dipeptide, a ligand for TLR-2. It has also been 
reported that responses to endotoxin were altered subsequent to inoculation of muramyl peptides 
into mice (Holmlund et al., 2002). Koga et al. (2010) have speculated that the co-expression of 
TLR2 and TLR-4 on both villous trophoblasts and intermediate trophoblasts could therefore play 
the role of a defence mechanism by stopping participation of these cells in potentially fatal 
reactions.  
In summary, TLRs in trophoblast cells play a key role in placental innate immunity.  However 
the exact function of TLRs in fetal tolerance is unknown. The mechanisms for regulation of the 
expression pattern and functional activity of TLRs during pregnancy are also still unknown.  
Further studies of TLRs at the maternal-fetal interface will aid in the elucidation of the 
mechanism that maintain the balance between fetal tolerance and pathogen defence (Holmlund et 
al., 2002).  
1.10 Lipopolysaccaride (LPS) and Lipopolysaccharide Binding Protein (LBP) 
 
Pathogen-associated structures such as LPS are recognized by PRRs and have the ability to 
stimulate the innate immune system. LPS is a major component in the outer membrane of Gram-
negative bacteria. It is a very effective activator of immune responses as its lipophillic 
component and the saccharide polymer is covalently linked to the anchor domain of the 
membrane (Sankala et al., 2002). The primary role of LPS is to stimulate mononuclear 
phagocytes, which then synthesize and secrete immunoregulatory and inflammatory cytokines 
such as IL-1, IL-6 and TNF-α (Gangloff et al., 2005). Endotoxin shock can occur due to 
excessive secretion of these cytokines, and LPS is found to mediate shock caused by Gram-
negative bacteria (Haziot et al., 1996).  
Cellular recognition of LPS necessitates that LPS binds lipopolysaccharide binding protein 




catalyst for the transfer LPS to the cell surface PRR CD14 (Gegner et al., 1995). .  Subsequent 
signal transduction is primarily mediated by CD14 and TLR-4,.Since CD14 lacks a 
transmembrane domain, TLR-4 is required to transmit signals across the plasma membrane 
(Anas et al., 2010). TLR-4, associates with LPS-bound CD14 along with myeloid differentiation 
factor 2 and transfers LPS, resulting in signal transduction (Gangloff et al., 2005). Recent studies 
have provided evidence that other receptors are involved in the mediation of LPS-induced cell 
activation, including TLR-2 and MARCO (Bowdish et al., 2009).  
Lipopolysaccharide (LPS), PAMP of Gram-negative bacteria, is recognized by the PRR, Toll-
like receptor (TLR-4). Cluster of differentiation (CD) 14 and macrophage receptor with 
collagenous structure (MARCO) are key PRRs. The hypothesis derived from the above is that 
MARCO is expressed on trophoblast cells and plays a valuable role in association with Cluster 
of Differentiation (CD14) in immune response through first hand surveillance of invading 
pathogens. The interaction of CD14 and MARCO was explored with the use of confocal 
microscopy which confirmed the colocalisation of these receptors in trophoblast cells suggesting 
they form physical associations contributing to their function at the feto-maternal interface.  
1.11 CD14  
 
CD14, the receptor for bacterial LPS, is a 55kDa glycoprotein. CD14 is initially processed in the 
endoplasmic reticulum and then expressed on the cell surface (Gegner et al., 1995). The protein 
is composed of 375 amino acids and it contains leucin-rich repeats which are significant in 
PAMP binding (Anas et al., 2010). CD14 binding of LPS occurs within a pocket of the CD14 
structure (Anas et al., 2010). CD14 is designated as an acute phase protein as its expression in 
liver cells is induced by the inflammatory cytokine IL-6 (Anas et al., 2010). 
CD14 exists in membrane bound (mCD14) and soluble (sCD14) forms. There are two different 




the LPS-induced cytokines TNF-α and IL-6, mediated by purified 48 kDa sCD14, has been 
observed (Labeta et al., 1993) 
1.11.1 Cell surface expression of CD14 
 
CD14 is mostly expressed on myeloid cell surfaces, including on macrophages, monocytes and 
neutrophils. In non-myeloid cell types, it is expressed on epithelial cells, endothelial cells and 
fibroblasts at comparatively low levels (Tobias et al., 1994). CD14 exists in two forms: 
glycosylphosphatidyl (GPI)-anchored membrane protein (mCD14), present on monocytes, and 
soluble protein (sCD14) in plasma (Heidenreich, 1999).  
1.11.2 CD14 cellular function 
 
CD14 serves as the main receptor for LPS (in the presence of LBP) and mediate responses to 
LPS (Heidenreich 1999). This was confirmed by Wright (1995), who reported that targeted 
disruption of the murine CD14 gene resulted in animals with at least 100-fold less sensitivity to 
LPS. The CD14-deficient mice were found to be highly resistant to endotoxin shock. However a 
minute amount of the inflammatory cytokines TNFα and IL-6 was synthesized at a LPS dose 
which is highly lethal for mice expressing CD14. This indicated the presence of CD14-
independent pathways of cellular activation. Furthermore the CD14-deficent mice unexpectedly 
survived and exhibited no symptoms of bacterial-induced shock when injected with a dose of 
Gram-negative bacteria (Escherichia coli.) lethal to normal mice. This presented a new role of 
CD14 in the dissemination of bacteria in of Gram-negative infections (Haziot et al., 1996).   
Recent studies have shown that CD14 is only of the components of a receptor complex which 
mediates the LPS-induced signal transduction. CD14 plays a significant role in this potent 
immune response through the transfer of LPS to the TLR-4: MD2 complex (Gangloff et al., 




CD14-independent pathway of signal transduction by different LPS chemotypes (figure 3). The 
majority of Gram- negative bacteria synthesize ‘smooth LPS’ (Gangloff et al., 2005). The 
smooth LPS is composed of the lipid moiety, a core polysaccharide and a variable O-
polysaccharide whereas the failure to attach either of the components other than lipid A moiety 
results in the formation of ‘rough LPS’.  In both the chemotypes of LPS, the lipid A moiety is the 
bioactive element which has pathogenic functions in infections caused by Gram-negative 
bacteria. Subsequent to induction with rough LPS, equal quantities of TNF was secreted by both 
the CD14-deficient murine macrophages and the CD14-expressed macrophages and no secretion 
to smooth LPS was observed. This signifies the necessity of CD14 for only the smooth LPS for 
the activation of TLR-4: MyD88 pathway. Furthermore no IFN-α/β was secreted upon 
stimulation with smooth or rough LPS which indicates that CD14 is required for TLR-4: TRIF 






Figure 1.3 Toll-like receptor signalling. (Koga and Mor 2008). 
CD14-independent and CD14-dependent signalling by Toll-like receptors.  MyD88-dependent 






LPS-induced activation of myeloid cells is not only dependent on the GPI- anchor of membrane 
CD14 (Heidenreich 1999). Cellular activation by LPS in cell types that have a low count of 
surface CD14, for example  epithelial and endothelial cells,  is also mediated by soluble CD14 
(sCD14) (Anas et al., 2010). SCD14 acts as a LPS receptor in cells that express no mCD14 
(Labeta et al., 1993).  
CD14’s multifunctionality is due to its ability to stimulate different PRRs. Yang et al. (1999) 
discovered that LPS- induced TLR-2 activation in monocytes is enhanced by the presence of 
mCD14b due its association with the TLR-2, which results in the formation of the LPS receptor 
complex. CD14 was also identified to facilitate the activation of monocytes by IL-2 Bosco et al., 
(1997) 
CD14 can participate in TLR activation by interacting with non-LPS PAMPs, including viral 
components.  Also, CD14 can enhance cell activation through the TLR-3 ligand poly (I: C), 
which transfers CD14 to TLR-3 and acts as a vital infection detector due to its ability to 
recognize viral nucleic acids. This evidently illustrates the role of CD14 in inflammatory 
responses (Anas et al., 2010). CD14 has been found to be receptive to most bacterial cell wall 
components as well Gram-negative bacteria including Gram- positive bacteria, fungi and 
spirochetes. (Heidenreich, 1999).It is responsible for the activation of several other PRRs 
stimulated by other bacterial PAMP’s, including peptidoglycan, lipoarabinomannan, 
phospholipids and LTA (Heidenreich 1999). Peptidoglican-induced activation of TLR-2 is 
reported to be mediated by CD14. However activation of mCD14-deficient epithelial and 
endothelial cells by peptidoglycan:- sCD14 complex is a failure in contrast to LPS induction. 
Moreover CD14 is found to enhance immune cells activity induced by LTA along with LBP 





1.11.3 Role of CD14 during pregnancy 
The expression of CD14 on trophoblast cells was first reported in 1993 (Guilbert et al. (1993).  
However, a comprehensive study of CD14 expression and its function in trophoblast cells has 
not been conducted. However placental infections initiated by Gram-negative bacteria is a clear 
indication of the presence of CD14 on trophoblast cells as it acts as the receptor of LPS, located 
on the outer membrane of the bacteria.   
The presence of the intracellular Gram-negative bacterium Chlamydia pneumonia has been 
correlated with vascular disease. During pregnancy, dissemination of C. pneumoniae into the 
peripheral blood may lead to infection of the placenta. C. pneumonia infection has been 
demonstrated to affect trophoblast viability and to result in decreased invasion capacity of 
extravillous trophoblasts via the extracellular matrix.  C. pneumoniae DNA has been detected in 
placental tissues, confirming the role of Chlamydiain the reduction of uterine wall invasion by 
infected extravillous trophoblast cells. In addition, a correlation has been noted between C. 
pneumoniae and preeclampsia:   antibodies against the bacteria were observed in the circulation 
of women with severe with preeclampsia (Han et al., 2011). Further studies will be necessary to 
elucidate the expression of CD14 in trophoblast cells and its role in innate immune responses. 
Such studies may assist the development of therapeutic strategies against trophoblast 
dysfunction.  
1.12 Macrophage Receptor with Collagenous Structure  
Scavenger receptors are immunosurveillance receptors which have been classified into a number 
of subclasses according to their tertiary structure (Thelen et al., 2010). Class A scavenger 
receptors (SR-As) are a collection of pattern-recognition receptors which consist of: SR-AI/II, 
Macrophage Receptor with Collagenous structure (MARCO), Scavenger Receptor with C-type 
Lectin (SRCL) and SCARA5 (Arredouani et al., 2006). MARCO is a trimer containing a 




et al., 2002). It is encoded by the gene located on chromosome 2 (Thelen et al., 2010). The 
majority of murine MARCO is expressed on the marginal zone macrophages in the spleen, on 
macrophages of the medullary cord in lymph nodes and on peritoneal macrophages (Granucci et 
al., 2003). The expression of human MARCO is detected to be most robust in the liver, lymph 
nodes, monocytes and alveolar macrophages which is involved in the filtration of blood and 
lymph fluids (Jozefowski et al., 2005). MARCO has the capability of binding both Gram-
positive and Gram-negative bacteria but not yeast (Granucci et al., 2003). 
1.12.1 Cell specific functions of MARCO 
 
MARCO may play a significant role in the innate host defence system. This is indicated by up-
regulation of MARCO during bacterial infections in the liver and spleen (Arredouani et al., 
2004). Thelen et al., (2010) reported that the degree of MARCO transcription and cell surface 
expression increase after bacterial binding which further supports its significance in 
phagocytosis. Moreover the expression of MARCO can be stimulated upon bacterial infection or 
LPS injection as LPS present on the Gram-negative bacteria acts as a ligand of MARCO 
(Sankala et al., 2002). However due to the ability to bind both Gram-negative bacteria and 
Gram-positive bacteria, MARCO has at least another bacterial ligand. Furthermore it was 
reported that MARCO binding to bacterial strains which express “rough LPS” was greater in 
comparison to strain which express “smooth LPS” (Sankala et al., 2002). Another factor which 
indicates the importance of MARCO in innate immune defence is its stimulatory effect on IL-12 
production in macrophages. The decrease in IL-12 production in peritoneal macrophages in 
contrast to wild type cells, stimulated by LPS proved MARCO mediation of this regulation. It 
was further confirmed by the increased IL-12 production due to MARCO ligation with a mAb 




It is apparent that MARCO is the major receptor in alveolar macrophages for unopsonized 
pathogens. Sankala et al. (2002) have demonstrated that genetically modified MARCO-deficient 
mice show impaired phagocytosis of Streptococcus pneumoniae in the lungs. Additionally, the 
neutrophil count in infected lung tissue from MARCO-deficient mice was significantly higher in 
comparison to wild type tissue. These data confirmed that MARCO-deficient mice have 
impaired ability in the capacity to clear of S. pneumoniae from the lungs, which leads to 
increased mortality. Therefore MARCO is a critical receptor in the innate immune response 
against inhaled particles and airborne pathogens. S. pneumoniae is a Gram-positive bacterium 
which is known as the main cause of community acquired pneumonia, bacteraemia and bacterial 
meningitis. Further studies of MARCO and its regulation will aid the development of therapeutic 
measures against pneumococcal infections. 
Cell surface expression of MARCO has been proven to be greater in SR-AI/II-deficient 
peritoneal macrophages than on. Thelen et al. (2010), reported that MARCO is more essential, in 
comparison to the SR-AI/II receptor in human decidual macrophage, for phagocytosis of 
Clostridium sordellii, a rare firmicute associated with infections of the reproductive tract. It was 
evident by the inhibition of phagocytosis by sMARCO, a specific MARCO-dependent inhibitor 
but not by AcLDL, a specific antagonist of SR-AI/II receptors. This was confirmed by 
observation of SR-AI/II-deficient mice, which display increased MARCO expression. This is 
hypothesized to cause greater phagocytic activity in SR-AI/II-deficient macrophages in 
comparison to wild-type cells. In addition, upregulation of MARCO expression in SR-AI/II-
deficient mice was confirmed by greater mRNA transcription of MARCO in SR-AI/II-deficient 
macrophages in comparison to wild-type cells. Moreover, MARCO function in human cells was 
further evidenced y the impaired ability of MARCO-deficient peritoneal macrophages to 
phagocytise C.sordellii. MARCO-deficient mice displayed enhanced susceptibility to mortality 




Hence, it was established that MARCO plays a significant role in innate defence against 
C.sordelli iin the uterus (Thelen et al., 2010). Toxic shock syndrome due to C.sordellii and C. 
perfringens was reported a mortality of 1 in 200 women of reproductive age. C.sordellii is an 
anaerobic, spore forming gram-positive bacteria related to highly lethal female reproductive tract 
infections, soft tissue infections and bacteraemia. C.sordellii infections of the reproductive tract 
emerge subsequent to childbirth and abortion. The expression of MARCO in the uterus and its 
function in defence against C.sordellii infection indicate that it might serve an important role in 
trophoblast cells.  
1.13 Myoferlin 
 
At cellular level, myoferlin is found in cell membrane, which is a membrane protein of 
cytoplasmic vesicles and nuclear membrane. At tissue level, however, it is profoundly 
communicated in skeletal and cardiovascular muscles while, feebly communicated in kidney, 
brain and placenta (Bernatchez et al., 2007; Davis et al., 2002). A research found that C2 area of 
myoferlin and different individuals from its family change the lipid pressing of plasma layers. 
Besides, myoferlin additionally encourage membrane parting and layer combination (Marty et 
al., 2013). Another examination uncovered that myoferlin controls the security and function of 
the vascular endothelial development variable receptor 2, along these lines, loss of myoferlin in 
endothelial cells created absence of cell multiplication, movement, and nitric oxide discharge 













1.13.1 Myoferlin: role in pregnancy 
Late studies have described that transformation or hereditary interruption of myoferlin advances 
strong dystrophy-related phenotypes in mice, which are the significance of debilitated plasma 
membrane integrity. Be that as it may, no biological functions have been credited to myoferlin in 
non-muscle tissue. Articulation of myoferlin alongside its family member dysferlin has been 
accounted for in the trophoblast placenta, where just dysferlin has been discovered to be 
connected with trophoblast cell combination (Robinson et al., 2009). Diminished appearance of 
myoferlin in trophoblast cells may prompt diminished cell expansion and as result lacking 
intrusion upon bacterial and/or viral contamination Myoferlin is connected with the constancy 
and purpose of the vascular endothelial development component receptor 2 (Bernatchez et al., 
2007).  
1.14 Vascular Endothelial Growth Factor (VEGF) 
 
A key regulator of angiogenesis is the Vascular Endothelial Growth Factor (VEGF) which has a 
significant function in conceptive functions, embryogenesis and skeletal development (Ferarra et 
al., 2003). VEGF also known as VEGF-A, is a member of the platelet-derived growth factor 
(PDGF) family, which also include VEGF-B, VEGF-C, VEGF-D, VEGF-E, VEGF-F and 
placental Growth Factor (PlGF) (Hoeben et al., 2004). In addition, different types of VEGF 
mRNA are generated as result of single 8- exon splicing of VEGF (Tischer et al., 1991). A few 
distinctive VEGF isoforms: VEGF121, VEGF145, VEGF148, VEGF165, VEGF183, VEGF189, 
and VEGF206 are formed as result of the VEGF splicing (Hoeben et al., 2004). The isoforms are 
named taking into account it’s quantity of amino acid residues. For instance, VEGF165 contains 
165 amino acid residues (Tischer et al., 1991). There are distinctive isoforms of VEGF; 
VEGF121, VEGF145, VEGF148, VEGF165, VEGF183, VEGF189 and VEGF206 as a result of 
gene splicing. However, VEGF110 is generated from proteolytic cleavage (Hoeben et al., 2004). 




through cells. For example, VEGF121 can diffuse unreservedly inside the cell as does not bind to 
heparin. Then again, VEGF165 is accepted to have in between characteristics, in this way it can 
be discharged out of the cell.  Although, a distinguishing amount of VEGF165 may remain in the 
cell surface and extracellular matrix. VEGF189 and VEGF206 proteins are concealed inside the 
extracellular matrix as a consequence of a high affinity of binding to heparin, (Park et al., 1993; 
Ferrara et al., 2003). VEGF receptor tyrosine kinases (RTKs); fms-like tyrosine kinase (Flt-
1/VEGFR-1) and kinase domain region also known as fetal liver kinase (KDR/Flk-1/VEGFR-2) 
regulates biological processes of VEGF.(Ortéga et al., 1999).  
1.14.1 Vascular Endothelial Growth Factor: role in pregnancy 
 
The expression of the receptors VEGFR-1 and VEGFR-2, VEGF and PlGF, has critical impact 
in proceeding placental angiogenesis (Pietro et al. 2010). VEGF is expressed by extra villous 
trophoblasts situated in the anchoring villi, in the placenta, (Ahmed et al., 1995). In addition, due 
to the significant role VEGF in pregnancy, impaired function of endothelial cells and pregnancy 
loss as found in the placenta of mice may cause as result of the decrease of VEGF secretion. 
Also embryonic lethality in mice appears to occur due to VEGF (Ferrara et al., 1996). 
Lipopolysaccharide is a key segment of the external membrane of Gram-negative bacteria. As 
most pregnancy complications occur due to maternal or fetal infection, this study is focused on 
the impact of bacterial LPS on the VEGF proteins inside the trophoblasts. The aim of the 
research is to study the VEGF proteins present in the cell line will damage and their response tp 








Placental development and vasculogenesis are dictated by communication between fetal 
trophoblast cells and maternal immune cells during pregnancy. Immune privilege, during 
gestation, is maintained by the release of mediators that enhance cellular communication.  
Among the soluble factors playing a role in promoting cell growth and development are 
chemokines; they are critical factors in this process.  
Chemokines are a family of structurally-related, small molecular weight, secreted proteins that 
promote chemoattraction. They are a group of seven transmembrane domain G-protein-coupled 
receptors. Even though chemokines were originally described as responsible for recruiting 
immune cells to arbitrate inflammation, they are also regarded as the agents, which control 
central nervous system development and haematopoiesis (Tran and Miller (2003).  
During placental development, cytotrophoblasts release CCL3/MIP-1 alpha and decidual 





 Natural Killer (NK) cells, respectively, from the maternal circulation (Hanna et al. 
(2003) and Drake et al. (2001). NK cells (dNK cells) deployed to the decidua responds to the 
local environmental prompts (e.g. IL-15) through modifying their phenotypic profile via down-
regulating their chemokine receptors. dNK cells lose their cytolytic activity after interacting with 
HLA-G, a key non-classical MHC Class I molecule expressed on trophoblast cells ((Hanna et al., 
2003); Kanellopoulos-Langevin et al. (2003) Hunt et al. (2006). A positive role for dNK cells 
were recently suggested by Hanna et al, which describe them as source of angiogenic growth 
factors following activation of the NK-activating receptor NKp44 by ligand-bearing 
cytotrophoblasts (Hanna et al. (2006) dNK cells release CXCL8/IL-8 and CXCL10/IP-10, in 












and vascular remodelling (Hanna et al. (2006) by these chemokines. Hence, the reciprocal 
attraction between dNK cells and invading trophoblasts, which is influenced by chemokines, 
appears to be integral for the development of an efficient maternal-fetal interface early in 
pregnancy.  
It has been suggested the regulation of the inflammatory response by chemokines has an 
influenced on miscarriage. According to a recent epidemiological research which examined 
chemokine levels in the serum of pregnant women revealed that increased concentrations of 
CXCL5/ENA-78 and CCL5/RANTES are linked with higher risk of miscarriage (Whitcomb et 
al., 2007). Even though these two kinds of chemokines have been localized to decidual cells, it is 
not too clear whether the placental imbalance is accurately represented through these circulating 
levels.  
Martinez de la Torre and colleagues research support a detrimental consequence theory of 
placental chemokines by reporting a beneficial role of the D6 chemokine receptor decoy in 
mouse fetal survival (de la Torre et al. 2007) D6 is a silent receptor expressed on lymphatic 
endothelium that scavenges pro-inflammatory chemokines, thus reducing ligand availability to 
signalling receptors Mantovani et al. (2006) After identifying D6 expression in human and 
mouse placenta, these authors further examined the impact of chemokines and D6 function in 
foetal immune privilege by administering  lipopolysaccharide (LPS) injection, an animal model 
of inflammation-related fetal loss, on pregnant wild-type (WT) and D6
-/-
 mice. Systemic LPS 
injection caused an increase in both circulating and placental levels of inflammatory chemokines 
CCL22/MDC, CCL2/MCP-1/JE and CCL11/Eotaxin in WT mice, with exaggerated levels in D6
-
/-
 animals.  
Furthermore, an increase in foetal loss is associated with LPS injection, with significantly higher 
frequency observed in D6
-/-




neutralizing antibodies to inflammatory cytokines, they were able to reduce the fetal losses, 
which were caused by LPS. Collectively, the integral part of the inflammatory chemokines in 
pregnancy was highlighted by the results and further recognises D6's protective role in 
pregnancy as a scavenger receptor (Martinez de la Torre et al., 2007). 
It could be assumed that future research will definitely focus on finding out how the fetal 
development is affect by chemokines, while addressing issues such as time, location, relative 
concentration, and cellular environment. It is vital to have data of that nature in order to find 
effective medicine for complications associated with reproduction such as infertility, miscarriage 
and preeclampsia. 
1.16 Infection and human pregnancy 
 
A developing fetus faces numerous risks during pregnancy. Complications such as intrauterine 
infections, which are generally seen during the early pregnancy, cause a substantial risk to the 
developing foetus. It is believed that through (i) maternal blood circulation, (ii) ascending into 
the uterus from the lower reproductive tract, or (iii) descending into the uterus from peritoneal 
cavity (Espinoza et al., 2006, Mor, 2008), pathogens can enter into the placenta.  
Larmont (2003) explains that intrauterine infections have been recorded in up to 40% of cases 
during the pre-term labour. In addition, Epstein et al., (2000), explain that in 85% of the cases 
that experienced a pre-term delivery at less than 28 weeks of gestation, have symptoms of 
infections. Furthermore, it is argued that it is quite possible for intrauterine infections to occur 
during the early pregnancy prior to any observed pregnancy complications (Gonçalves et al., 
2002). It is also said that several types of complications are mainly associated with particular 
stages of a pregnancy. For instance, a complication such as miscarriage is a common occurrence 




during any phase of the pregnancy (Arechavaleta-Velasco et al., 2002, Romero et al., 2003, 
Gonçalves et al., 2002). When considering the pre-term labour and early miscarriage during the 
first trimester of pregnancy, bacterial infection has been distinguished as a major cause that 
triggers those complications (Romero et al., 2010, Kim et al., 2010, Ralph et al., 1999, Hay et al., 
1994, Romero et al., 2007).  
Toxins, which stimulate cytokine production including interleukin-6 (IL-6), tumour necrosis 
factor α (TNF-α), chemokines (such as IL-8), interleukin-12 (IL-12) and IFN-γ (Romero et al., 
2007, Filisetti and Candolfi, 2004), prostaglandins (Patel and Challis, 2001), proteases and other 
enzymes (Phillippe et al., 2001, are usually released during a bacterial infection. All of these 
contribute in forming a coordinated response which is responsible in causing uterine 
contractions, and placental detachment. Therefore, it is very clear that the role of the human 
placenta is integral for the protection of the fetus and the comprehension of it is not easy either 
as it is not very well explained. The phrase ‘toll-like receptors’ (TLRs) which are members of the 
pattern recognition receptors (PRRs) family and are expressed at the fetal-maternal interface 
such as TLR-2 and TLR-4 (Holmlund et al., 2002, Kumazaki et al., 2004, Patni et al., 2009), 
have been sown in former studies in placenta trophoblasts.  
One of the major components of the outer membrane of gram negative bacteria is called 
Bacterial lipopolysaccharide (Poltorak et al., 1998, Qureshi et al., 1999). It has been identified 
that around 90% of the surface of the outer bacterial ell is covered by Bacterial 
lipopolysaccharide. The purpose of this component is to guard the bacteria through serving as 
physical barricade (Nikaido, 1989; Papo and Shai, 2005). Its constituents both hydrophobic and 
hydrophilic domains are vital for the survival of the bacterial as well defend it for deprivation of 




In summary, it has been assumed that PRRs in trophoblast cells are essential to protect the foetus 
from pathogens and could be mainly responsible for the maternal innate immune system. 
However, their purpose with regard to the fetal tolerance by the maternal immune system is yet 
to be clarified. Hence it is essential to carry out additional studies on CD14 and MARCO in 
order to clarify the expression of CD14 in trophoblast cells and its role in innate immune 
responses. The new discoveries might lead to the creation of therapeutic strategies against 





 Materials and Methods  
2.1 Materials 
2.1.1General laboratory chemicals  
 
The majority of chemicals used in this study were from Sigma, Poole, England, UK, particularly, 
Accutase, Dimethyl Sulphoxid (DMSO), Cellytic M Cell Lysis Reagent, Protease Inhibitor 
Cocktail, Paraformaldehyde (PFA), Tween-20, Saponin and Triton-X 100. Other chemicals such 
as Sodium Chloride, Acetone, Methanol and Virkon were from Fisons, Leicester, England, UK; 
Fetal Calf Serum (FCS) was from Imperials Laboratories, England., Germany. 
Lipopolysaccaride (LPS) from E. coli serotype EH100 was purchased from (Sigma Aldrich, 
UK). Dulbecco's Modified Eagle's Medium (DMEM) and RPMI were from Fisher Scientific, 
UK. 
2.1.2 Cell lines 
 
For the purpose of the present study, we employed human placental cell line JEG-3. Secondly, 
we included other cell lines in the present study as positive controls such as THP1, and Raji. The 
human placental choriocarcinoma cell line JEG-3 provided by Prof. I.L. Sargent, Nuffield 
Department of Obstetrics and Gynaecology, University of Oxford. This cell line is an epithelial 
adherent monolayer which is highly proliferative, so it was suitable for use as our trophoblastic 
model system. This cell line was maintained in DMEM/Hams F-12 which was supplemented 
with 10% (v/v) FCS, and maintained at 37°C and 5% CO2. Secondary cell lines were used in the 
present study as a positive control since they express a considerable level of CD14 and MARCO. 
The secondary cell lines that were used in this study are as follows: THP1, a human monocyte 




lymphoma. All secondary cell lines were kindly provided by Prof. Nelson Fernandez, 
Department of  
Biological Sciences, University of Essex, UK. The cell lines were cultured in RPMI -1640 
medium and were maintained at 37°C and 5% CO2. 
2.1.3 Antibodies 
 
The primary and secondary used in this study were obtained from different sources as shown in 
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2.2.1 Cell cultures of cell lines 
 
The JEG-3 cell line was of immense importance for all the experiments of this study as it served 
as the model with which the placenta could be compared. JEG-3 cells were passaged at 70-80% 
confluency every 3 to 4 days. The cells were washed with 1X Phosphate buffer saline (PBS) and 
lifted with 1ml of accutase (Sigma-Aldrich; Dorset, UK) by incubating at 37°C for about 5-10 
minutes. The cells were then counted with a hemocytometer and plated out at a density of 1X10
3
 
in a new culture flask. THP1 cell lines were expanded differently as they .are suspension cell 
lines. The cells were centrifuged at 1000 rpm for 5 minutes, supernatant was aspirated and fresh 
medium was added to the cell pellet. Then cells were seeded at density of 1X10
5
 in a new culture 
flask. 
2.2.1.1Cryopreservation of cells 
 
Cryopreservation of cells was done at 70% confluency. The cells, by means of accutase, were 
detached, counted and checked for feasibility as mentioned above and then centrifuged. Then the 
re-suspension of the cells was carried out and as a result they were approximately 1.25 x 106 
cells/ ml of freezing mixture (90% FCS and 10% Dimethyl sulfide [DMSO]). Afterwards, 1 ml 
of the cell suspension was then dispensed into each cryo tube (Fisher Scientific, UK) and placed 
in -80̊ C freezer for 1-2 days before transferring them to liquid nitrogen at -196̊ C for long-term 
storage.  
2.2.1.2 Growth curve 
 
JEG-3 cell line, which grows in culture, is grown in three separate phases. ‘Lag phase’ which is 
the first stage, spans into 1- 2 days. During this period cell numbers increase slightly. It has also 




stage is called the ‘log phase’ in which an exponential surge in the cell numbers are visible. 
Then, the final phase is the ‘confluent phase’. During this phase, the number of 
2.2.1.3 Cell Viability Test 
Cell viability was tested to identify whether the cells were dead or living, based on the trypan 
blue exclusion method. Firstly, the cells were washed with PBS. Then accutase treatment was 
used to split them and the cell suspension was placed in a conical centrifuge tube. Then a cell 
suspension of 1:2 dilutions in trypan blue (Sigma, UK) was prepared. Approximately 10µl of 
diluted cell suspension was loaded into both the haemocytometer chambers, and cells were 
viewed under the light microscope. The cells were observed as total cells and non-viable (blue) 
cells. Live cells would have the cell membranes intact and would exclude the trypan blue dye, 
where dead cells did not. 
2.2.2 Cell Stimulation 
2.2.2.1 Lipopolysaccharide (LPS) 
LPS is unique for gram-negative bacteria presented in the outer membrane, and is made of both 
hydrophobic and hydrophilic domains and was purchased from (Sigma Aldrich, UK) in freeze-
dried powder. LPS was dissolved in 1ml of sterile 1X PBS (1 mg) by swirling gently until the 
powder dissolved. Solutions were further diluted to the desired working concentration with 
additional sterile cell culture media, and were stored at -20°C in accordance with the 
manufacturer’s instructions. JEG-3 cells were serum starved with DMEM/Hams F-12 and Ham’s 
F-12 respectively containing 0.1% FCS, for a period of 4 hrs prior to stimulation. Cells were then 
stimulated with LPS at a concentration of 1, 10 and 20µg/ml, at the following time points; 1 2 , 
24 and 48 hours. Cells were counted using a haemocytometer, checked for viability and 




2.2.3 Protein expression analysis using Flow Cytometry 
 
Flow cytometry is a technique used to analyse and measure various properties of cells. The cells 
are usually labelled with a fluorescent probe, normally a fluorphore conjugated to an antibody. 
The cells are suspended in fluid; and the cells carrying fluid are passed through a beam of light. 
This technique uses the principles of light scattering, light excitation, and the emission of 
fluorochrome molecules to generate specific multi- parameter data from cells. There are three 
parameters that are measured by photomultiplier tubes; forward scatter (FSC), side scatter (SSC) 
and fluorescence (FL). One advantage of the flow cytometer is its ability to evaluate a large 
population of cells accurately and quickly with semi quantitative results. This makes flow 
cytometry an ideal tool for quantitative analysis of certain cellular properties, especially when 
the cells of interest are a small fraction of other cell types in a cell population. The results are 
displayed in many ways, such as in a histogram, dot plot or contour. As standard practice, 
irrelevant or nonspecific isotype antibody was used as a negative control so that we can evaluate 
the degree of positivity for other surface proteins in terms of the fluorescence intensity. 
2.2.3.1 Cell surface and intracellular staining 
 
For surface staining of specific cell antigens, such as, HLA-ABC or HLA-DR, VEGF, after 
culturing treated or untreated samples (1 × 10
6
 cells/ sample), cells were washed in PBS. The 
cells were fixed with a fixation buffer to ensure free access of the antibody to its antigen 4 % 
PFA (Sigma, UK) and this was followed by a washing step in PBS. The cells were then blocked 
with blocking buffer (0.1% BSA in PBS) to block non-specific antibody binding sites, then 
washed again in PBS. Cells were used with either only secondary antibody or neither primary 
nor secondary antibody as negative controls. For intracellular staining, cells (antigens such as 
Myoferlin) were permeabilised with 0.25% Triton X-100 in PBS for 10 min. on ice... The 




10,000 cells each were analysed using a BDFACS Aria Flow Cytometer using a 488 nm beam 
for detection of the fluorochrome attached to the secondary antibody (PE, FITC). 
2.2.4 Proteomics 
2.2.4.1 Protein extraction 
 
Cell lines grown up to 70-80% confluence were washed twice with PBS and frozen down at -80 
ºC until used for cell lysates. To prepare whole cell lysate, CelLyticTM M reagent (Sigma-
Aldrich) (contains low percentage of a mild detergent in bicine buffer) and protease inhibitor 
(Sigma-Aldrich) were mixed at 100:1 ratio respectively and added to frozen cells and scraped 
with a cell scraper. Cells with reagents were then transferred into a micro-centrifuge tube and 
incubated on ice for 20 minutes and then vigorously vortexed. Lysed cells were ultra-centrifuged 
at 20,000×g for 10 minutes. For further analysis Supernatant was collected and stored at -80
o
C. 
ProteoJETTM Cytoplasmic and Nuclear Protein Extraction kit (Fermentas, Thermo Fisher 
Scientific) was used according to instructions provided with the kit to prepare cytoplasmic and 
nuclear protein fractions. Total protein concentration was determined by the Bio-Rad Protein 
Assay (Bio-Rad, Hercules, CA, USA) following the manufacturer’s instructions. 
 
2.2.4.2 Bradford Assay 
This technique is utilized for measuring the protein concertation in the lysate in order to calculate 
the quantity of protein that ought to be stacked into every well before running the gel. This 
measure depended on the importance that when the Coomassie Blue Dye is bound to the protein 
in an acidic medium, a movement in absorbance happens from 465 nm-595 nm bringing about a 
colour change from chestnut to blue. The measure of complex now appeared in the solution is a 
measure for the protein concentration by technique for an absorbance analysing. Standard 




were readied. A progression of weakening for the example was set up in PBS. 5 l of the models 
and tests separately were added to a 96 well-plate. 250 microliters of Bradford reagent was 
added to every well and the plate was left for incubation at room temperature for 5 minutes. A 
miniaturized scale titre plate peruse was set up to an absorbance of 595 nm. To minimize test 
mistake the plate was read three times. A graph for concentration versus absorbance was plotted 
on Microsoft Excel and the protein fixation was acquired utilizing the y = mx + c condition.  
2.2.4.3 One dimensional gel electrophoresis 
 
This method uses the molecular weight of the polypeptide to separate it. The capability of a 
molecule to move over an electric field is directly proportional to the voltage and the charge of 
the molecule, while inversely proportional to the molecular friction. Considering that, a semi-
solid matrix at a set voltage can separate the proteins electrophoretically taking into account their 
molecular weight. When the molecules are charged to the same degree and the same sign, the 
portability of the molecules would be contrarily proportional to their size. In this way, in PAGE, 
the proteins are negatively charged and are bound to sodium dodecyl sulphate (SDS) and are 
separated within a matrix of polyacrylamide gel in an electric field based on their molecular 
weights. 
After 12% gels were set up with the BioRad Mini PROTEAN Electrophoresis system, TEMED 
and APS were added to improve the polymerization process. Once the gels were completely 
polymerized, they were loaded with electrophoresis buffer into the system. The previously 
measured protein lysate was used as sample preparation. The mixture of 20µl of protein and 5µl 
of sample buffer was heated on a dri-block at 95°C for 4 minutes, and then were loaded into the 
wells of the gels. Then the gel was run at 50V until the samples crossed the stacking gel and then 




Coomassie Blue to check the success of the transfer or processed for immunoblotting. Recipes 
for buffers and solutions are mentioned in the appendix. 
2.2.4.4 Coomassie Blue staining 
The polyacrylamide gel was prudently expelled from between the plates and afterward put into. 
Coomassie blue stain, the gel is covered totally, for 2 hrs at room temperature on a shaking table. 
Taking after that, the gel was put into 100ml of destain arrangement and supplanted with new 
one until the gel was clear and just the stained protein groups were noticeable. Formulas for 
buffers and solutions are in the appendix. 
2.2.4.5 Western transfer 
After protein detachment utilizing electrophoresis, proteins were exchanged to a polyvinylidene 
fluoride (PVDF) film (Immobilon-FL, Merck Millipore, Merck KGaA, Darmstadt, Germany) the 
gels is placed in a transfer buffer in the gel framework. Two gel cartridges were lined with a 
wipe and the gels were situated on channel paper over the wipe. The methanol pre-splashed 
PVDF membrane was situated over the gel while an extra channel paper and wipe were stacked 
on the above. A glass pipette was moved over to dispense with air bubbles, and the two 
cartridges were situated into the BioRad Mini PROTEAN Electrophoresis framework. At that 
point a cooling unit and exchange cradle were included, and the framework was run overnight at 
30 V. Toward the end of the exchange time frame, the framework was separated from a force 
supply unit and the gel likewise stained with Coomassie blue stain to check the achievement of 





To fix the protein on the membrane, they were washed with PBS and air dried then soaked in 
methanol for one minute. With 5% skimmed milk in PBS, membranes were blocked. To detect 
the proteins of interest, the following mAb were used: anti-CD14 (clone MEM-18) anti-MARCO 
(clone 2G12), anti-Myoferlin (clone FER1L3) and anti-VEGF (clone A-20). To probe the cell 
extracts an alpha-subunit specific tubulin antibody (TU02), beta-subunit specific actin (Poly 
6221) and Heat shock protein (Hsp 90) was loaded as a control. Captured proteins were detected 
by secondary antibodies Infra-Red Dye IRDye® 680LT Goat anti-mouse and IRDye® 800CW 
Donkey anti-Mouse IgG (Li-CorBioescieces, Lincoln, NE, U.S.A.) at a dilution of 1:10,000 in 
PBS with 5% milk and 0.025% Tween-20 (Sigma-Aldrich). Using the ODYSSEY infrared 
imaging system (Li-Cor Bioscience) signals were detected. To estimate the molecular weight of 
the proteins under study we used PageRulerTMPlusPrestained Protein Ladder from Fermentas 
(Thermo Fisher Scientific). 
2.2.5 Laser scanning confocal microscopy 
Confocal laser scanning microscopy is a valuable technique used to obtain three-dimensional and 
high-resolution images of very small objects. It is far superior in comparison to conventional 
microscopes due to many factors; firstly to be able to control the depth of the field, secondly 
minimal interference in background from the focal plane and thirdly: thick specimens can be 
studied in serial sections. 
In order to avoid distortion of image and minimizing blur due to sections above and below the 
focal plane of the specimen, Laser scanning confocal microscopy was used in this study to get 
clear visualization cellular components in contrast to standard fluorescent microscopy.  
Confocal microscopy permits the optical sectioning and achieving the three dimensional (3D) 




labeled specimen, which emits fluorescent light as a result. The fluorescent light is further passed 
through dichroic mirror with a pinhole source focused at the detector, which records the data on 
a computer. Thus light emitted from out of focus points are excluded. A 3D image Is achieved by 
horizontal and vertical scanning of the cells labeled section using motor driven mirrors. 
2.2.5.1 Immunofluorescence staining for microscopy 
Cell monolayer culture and twofold staining: JEG-3 cell lines were independently refined in 
LabTek 8 well chambers (Thermo Fisher Scientific) at a density of 6X103 cells for every well, 
for two days taking after seeding. However, for the staining technique, every one of the steps 
was done at room temperature. By using 4% paraformaldehyde the cells were settled (Sigma, 
UK) for 20 minutes and hindered with 2% (w/v) BSA arranged in 1x PBS (phosphate support 
saline) for 1 hr at room temperature. The incubation steps were additionally completed at room 
temperature. For staining, the cells were incubated with a particular monoclonal immune 
response for 1 hr took after by washing three times with PBS. The optional immune response 
utilized was hostile to mouse IgG conjugated with Alexa Fluor® 488 or Alexa Fluor® 555 
(Invitrogen, Carlsbad, CA, USA), these were incubated for 1h. For twofold staining, cells were 
blocked again for 1h and afterward stained with particular monoclonal counter acting agent for 
1h. After 3 washes, cells were brooded with against mouse IgG TRITC conjugated counter 
acting agent for 1h. Isotype controls were stained with just optional counter acting agent. Cells 
were then altogether washed and chambers were expelled from the slide. Slides were washed in a 
container containing 1X PBS and dried. The cells were then mounted with against blur mounting 
medium and precisely secured with the spread slip keeping away from any air bubbles. Edges of 
the spread slip were fixed with straightforward nail clean and dried noticeable all around. 





2.2.5.2 Microscopy for colocalisation studies 
Image acquisition for colocalisation studies was performed as described in Obara et al. (Obara et 
al., 2013).  Using a Nikon A1R confocal microscope with a plan-apochromatic violet corrected 
(VC) 1.4 numerical aperture (N.A.) 60x magnifying oil-immersion objective cell images were 
obtained. Images were acquired using one-way sequential line scans in four channels. With a 
laser power 3.2 arbitrary units (AU), DAPI was excited at 405nm and its emission collected at 
450/50nm with a PMT gain of 118 AU. Alexa Fluor 488 was excited at 488nm with a laser 
power 7.8 AU, its emission collected at 525/50nm with a PMT gain of 140 AU (hereafter called 
the green channel). Alexa Fluor 555 signal was excited at 561nm with laser power 2.1 AU and 
collected at 595/50nm with a PMT gain of 117 AU (hereafter called the red channel). 
Differential interference contrast images were acquired using the transmitted light detector at a 
gain of 103 AU. In all cases, no offset was used, and the scan speed was 1⁄4 frames/s (galvano 
scanner). The pinhole size was 34.5µm, approximating 1.2 times the Airy disk size of the 1.4 
N.A. objective at 525nm. Scanner zoom was centered on the optical axis and set to a lateral 
magnification of 55nm/pixel and a Nyquist factor of 2.54 (for Alexa Fluor 488) and 2.79 (for 
Alexa Fluor 555). Axial step size was 140nm, with 40-60 image planes per z-stack. Both 
channels were examined of the cells with average to fair signal strength. Cells were in isolated 
positions with few or no neighboring cells, allowing accurate quantitation of the flat plasma 
membrane and uncrowded receptor distribution.  
In order to reliably determine colocalisation with this method, optimized samples were acquired 
considering following criteria. First, saturated pixels were avoided, as they are the endpoint of 
the dynamic range. Values above this were not recorded, and saturated pixels may represent lost 
information and therefore were not used for quantification. Second, datasets were acquired with 
the correct sampling parameters. These are determined by the Nyquist-Shannon reconstruction 




image, as determined by the microscope’s resolution using Abbe’s criterion, should be 
represented by at least two pixels. Higher sampling (three to four pixels) is also acceptable, but 
under sampling must be avoided. Third, aberrations were minimized in the imaging setup. This 
was done by using objective corrected for spherical („plan‟) and chromatic aberrations 
(achromatic, apochromatic and apochromatic violet-corrected (VC), depending on the number of 
colours corrected for). Furthermore, uni-, not bi-directional scanning, zooming in to the center of 
the field of view, and separating colours in line scanning rather than full-frame mode was done 
as measures for minimizing aberrations.  
2.2.5.3 Colocalisation analysis 
An innovation strategy stated in Jabeen et al (2013) and Obara et al (2013) was taken after for 
this examination. The colocalisation approach utilizes MATLAB programming (variant R2010b 
with Image Processing Toolbox; MathWorks Inc., Natick, Massachusetts) and depends on a 3D 
blob-like component recognition calculation presented by Obara and colleagues. All process is 
depending on examination in 3D. The algorithm is separated into two phases: competitor area 
recognition, and applicant area pruning. After obtaining of discrete datasets for both atoms 
particles, the fluorescent force of particles is upgraded while smothering the sound by 
convolving the image with a 3D Laplacian of Gaussian (LoG) portion. The LoG piece size is 
controlled by a client characterized sweep r. Local maxima, recognized by morphological 
opening, are then used to characterize all areas of particles brighter than their prompt 
environment. This procedure proceeds until a client characterized low power bound T (separate 
for every channel, to consider datasets where sound levels are notably diverse) is touched. This is 
the edge beneath which no particles can be securely distinguished in light of image sound. So as 
to precisely gauge colocalisation of particles in the double shading fluorescence images, their 
centroid positions were pinpointed at subpixel determination utilizing weighted centroids. A 




between the two vectors of meeting positions, utilizing the normal range of the nearby circle of 
light r. For every position in one channel, we calculated the Euclidean separation for each 
position in the other channel. On the off chance that the separation of the nearest combine is 
lesser than the most extreme colocalisation separation d, then the pair is added to the rundown of 
matches and expelled from the input vectors. All competitor areas are pruned to kill spurious 
areas because of image noise. The method is rehashed until there are no more matches fulfilling 
the greatest colocalisation separation condition. Receptor sets were regarded to colocalise on the 
off chance that they didn't surpass the measurement deciding the estimated size of a solitary 
molecule's PSF. A tight limit was decided for this PSF, measuring 165nm in x and y, and 412nm 
in z. Receptor sets with their centroids facilitate separated than 165nm were named non-
colocalising. These outstanding positions in both datasets are then named as unmatched 
2.2.5.4 Visualisation 
Following loading the system's Graphical User Interface (GUI) and a 3D dataset for every 
channel, the calculation is controlled by pressing the "Colocalisation" button. Outcomes can then 
be observed in five diverse ways: 1) Stacks: Centroid positions of every distinguished particle 
are set apart by red dots in the image stacks, and sliders (in the "Stacks" box of the GUI) permit 
to travel through the distinctive z-planes. A high zoom can be applied to confirm the precise 
location of a super resolved centroid situated inside a fluorescent blob. 2) Maximum intensity 
projections: Visualisation of a whole dataset in one image where projections of every image 
stack are accessible ('Projection 1' and 'Projection 2' in the "Plot" box), with green and red 
reference marks stamping unmatched (non-colocalising) particles, and green and red asterisks 
with blue circles showing colocalisation. 3) Scatterplot: Produces an isometric viewpoint 
perspective of particles appeared as reference asteriks (green and red for every channel), and 
colocalisations enclosed in blue. The numbers for colocalisations and particles identified in every 




utilized to imagine colocalisations. Every colocalisation is appeared as a solitary circle, with a 
colour code demonstrating the separation between the two colocalising particles  
2.2.5.5 Pearson’s correlation coefficient for colocalisation 
Pearson’s correlation coefficient (PCC) for colocalisation was performed by using colocalisation 
threshold plugin in ImageJ with auto threshold settings. Three dimensional microscopic images 
were used for the analysis and value of PCC indicates the correlation between CD14 and 
MARCO receptors. Composites of merged red and green channels and their scatter plots were 
used. In THP1 cell line PCC value is 0.925, thus indicating strong positive correlation between 
CD14 and MARCO receptors. In JEG-3 cells, PCC value is 0.737, thus reflecting a strong 
positive association between the two receptors 
2.2.6 MTT Cell proliferation assay 
Trophoblast JEG-3 cells were cultured in 96 well flat bottom plate (Nunc) with seeding density 
1x10
4 
cells per well in 100µl complete culture medium. To synchronize the cell cycle, cells were 
stressed for 4h with low serum density (0.1% FBS) in culture medium at 60% confluence. Cell 
cycle synchronization is related to serum starvation of cells (Chen et al., 2012). Cells were 
subjected to infection, cells were treated with by lipopolysaccharide (LPS) serotype; O5:B55 
(Sigma) treatments (1µg/ml, 10µg/ml, or 20µg/ml) or no treatment (low serum medium only). In 
parallel-untreated cells was continued as a positive control for cell proliferation and for negative 
control a cell apoptosis inducing agent Camptothecin (Sigma) was used at a concentration of 
4mMolar solution in serum free culture medium. CellTiter 96 Aqueous one solution cell 
proliferation assay kit (Promega) was used to assess cell growth and proliferation. To determine 
live cells, each well was briefly subjected to 20µl cell proliferation reagent and incubated at 
37
o




colored product produced is directly proportional to the number of live cells, as only live cells 
react with the cell proliferating reagent. Elisa plate reader was used at a wavelength of 490nm to 
read the plate for measuring the absorbance. Before analysis background absorbance was 





Chapter 3  
Analysis of expression of CD14 and MARCO in human choriocarcinoma 
JEG-3 cells  
3.1 Introduction 
The aim of this chapter is to analyse the expression of cluster of differentiation (CD_) 14 and the 
scavenger receptor macrophage receptor with collagenous structure (MARCO) in the human 
placental choriocarcinoma cell line JEG-3.The maternal–fetal interface represents a unique site 
that must promote tolerance to the semi-allogenic fetus, whilst maintaining host defence against 
a diverse array of possible pathogens. CD14 is one of the components of a receptor complex 
which mediates LPS-induced signal transduction (White and Demchenko, 2014). MARCO can 
also interact with LPS. It has been suggested that MARCO plays a role in up-regulation of the 
antimicrobial defence system during bacterial infections in macrophages of the liver and spleen 
(Arredouani et al., 2004). CD14 is a 55kDa glycoprotein which is initially processed in the 
endoplasmic reticulum and then expressed on the cell surface (Gegner et al., 1995). CD14 exists 
in two forms as glycosylphosphatidyl (GPI) -anchored membrane protein (mCD14) on 
monocytes and as soluble protein (sCD14) in plasma (Heidenreich 1999).  
CD14 is a receptor for complexes of bacterial lipopolysaccharide (LPS) and LPS binding protein 
that mediates responses to LPS (Heidenreich, 1999). CD14 also recognizes other pathogen-
associated molecular patterns, such as lipoteichoic acid (Lotz et al., 2004). CD14-deficent mice 
survive and exhibit no symptoms of bacterial-induced shock when injected with a dose of Gram-
negative bacteria (Escherichia coli.) lethal to normal mice. This presented a role for CD14 in the 
dissemination of Gram-negative bacterial infections (Haziot et al., 1996).  
Since CD14 is GPI-linked, its role as co-receptor for the detection of LPS requires the protein 




mediated transmembrane signalling (Akashi et al., 2003).Binding of LPS to cell-surface TLR-4 
initiates myeloid differentiation factor 88/IL-1R-associated protein kinase/TNFR-associated 
factor 6 complex formation inside the cell. Signal transduction events then trigger activation of 
the IκB kinase-NF-κB pathway, and of Ser/Thr protein kinases that belong to ERK 1 and 2, JNK 
and p38 MAPK subfamilies (Akira et al., 2004; Zhang et al., 2004) 
MARCO is a multifunctional trimeric glycoprotein that contains a collagenous domain and a C-
terminal scavenger receptor cysteine-rich (SRCR) domain (Sankala et al., 2002). It is encoded by 
the gene located on chromosome 2 (Thelen et al., 2010). The expression of human MARCO is 
detected to be most robust in the liver, lymph nodes, monocytes and alveolar macrophages, 
which are involved in the filtration of blood and lymph fluids (Jozefowski et al., 2005; Thelen et 
al. 2010) reported that the degree of MARCO transcription and cell-surface expression increased 
after bacterial binding. This supports its significance in phagocytosis of bacteria.  
Because of the similarity in spatial expression and function (both ligands for LPS) hypothesis of 
the study was that these receptors might be working in close association. Therefore, one of the 
aims of the present study was to investigate the biological interaction between CD14 and 






AIMS OF STUDY: 
1. Expression of CD14 and MARCO receptors on trophoblast cells 
2. Colocalisation analysis for CD14 and MARCO receptors expressed on the surface of 




3.2 Results  
 
3.2.1 Viability, granularity and size of the trophoblast cells  
Flow cytometry was used to assess the granularity and viability of JEG-3 cells, B lymphocyte 
cells from a human lymphoblastic cell line (Raji) and THP-1 monocytes. Unstained cells were 
used for this test. Scatter plots are displayed as forward scatter on x-axis verses side scatter on y-
axis, where each dot on the plot area represents a cell (Figure 3.1) .Each plot area is divided into 
four quadrants, maximum density of the cells in all three cell lines is localised in the lower left 
quadrant, which revealed that cells were of the same size, granularity and that the majority of the 












Figure 3.1: Scatter plots displaying forward scatter (FSC) (X-axis) and side scatter (SSC) 
(Y-axis) of JEG-3, Raji and THP-1 cells. 
The FCS scatter data provide information on the relative size of the cells, whereas SSC scatter 
data estimate their granularity. The units indicate the level of light scatter brightness with 0 being 
the dullest and 1000 being the brightest. Each dot is a cell ranked by its brightness. The data are 






3.2.2 Cell-surface expression of HLA-A, HLA-B, HLA-C and HLA-DR 
 
The cell-surface expression of HLA-A, HLA-B, HLA-C and HLA-DR molecules in JEG-3 and 
THP-1 cells was studied in order to examine the immunogenicity of these cell lines and their use 
as models of trophoblast and monocyte cells.Results are presented as hitogramswhere mean 
fluorescence intensity (MFI) is along horizontal axis (x-axis) versus total cell count on vertical 
axis (y-axis) (Figure 3.2). In the flow cytometry analysis, empty histograms show HLA proteins 
expression while gray filled histograms represent isotype-matched negative control.  
It was found that JEG-3 and THP-1 cells express classical HLA class I molecules, HLA-A, 







         
 
Figure 3.2: Expression of cell-surface HLA-A, HLA-B, HLA-C and HLA-DR in JEG-3 and 
THP-1 cells. 
Flow cytometry analysis of JEG-3 and THP-1 cells showing HLA-A, B, C and HLA-DR 
expression (empty histograms), displayed as mean fluorescence intensity at the cell-surface . 
Negative controls were performed by using an isotype-matched control antibody (black-filled 





















































































































3.2.3 Phenotyping of CD14and MARCO in JEG-3 cells  
Flow cytometry analysis of cell-surface expressed CD14 was performed on untreated THP-1 and 
JEG-3 cells. The cells were stained with an appropriate concentration of CD14 monoclonal 
antibody (MEM-18) followed by fluorescent (FITC) secondary antibody. Cells without staining 
and isotype cells stained with only the secondary antibody were used as a negative control. 
Untreated THP-1 cells were used as the positive control.  
The analysis revealed a moderate expression of CD14 on the cell surface membrane of untreated 
JEG-3 cells, whereas, positive control THP1 cells showed strong expression (Figure 3.3A). The 
geometric means values obtained from flow cytometry analysis are presented as bar graphs (Fig. 
3.3B) which show mean fluorescence intensity (MFI) of each cell line in comparison to isotype 
control. 
Flow cytometry analysis of cell surface MARCO receptor expression on test cell line JEG-3and 
positive control cell line THP1 is shown in figure 3.4 A, where filled histograms are isotype 
controls and line histograms represent MFI indicating level of expression. JEG-3 cell line had 
reasonable expression of MARCO whereas, THP1 showed good expression for the same 
receptor. Geometric means of MFI are further presented graphically (Fig. 3.4B) showing 







Figure 3.3: Analysis of the expression of cell-surface CD14 in JEG-3 cells. 
Flow cytometry analysis showing CD14 expression (empty histograms), displayed as mean 
fluorescence intensity, on the cell-surface of JEG-3 and THP-1 cells. Surface expression of 
CD14 in THP-1 cells is shown as a positive control. Negative controls were performed by using 
an isotype-matched control antibody (black filled histograms). (B) Graphical representation of 
CD14 surface protein expression in JEG-3 and THP-1 cells. Bar graphs represent level of each 








Figure 3.4: Analysis of the expression of cell-surface MARCO in JEG-3 cells. 
(A) Flow cytometry analysis showing MARCO expression (empty histograms), displayed as 
mean fluorescence intensity, on the cell-surface ofJEG-3 and THP-1 cells. Surface expression of 
MARCO in THP-1 cells, which served as a positive control. Negative controls were performed 
by using an isotype-matched control antibody (black filled histograms). (B) Graphical 
representation of MARCO surface protein expression in JEG-3 and THP-1 cells. Bar graphs 
represent the level of each protein in mean values ± SD in each cell line. Data are representative 







3.2.4 Immunoblot analysis of CD14 and MARCO  
Western blotting was performed in order to investigate expression of CD14 and MARCO in 
whole cell lysates of JEG-3 and THP1 cells. THP-1 cells were used as a positive control, 
whereas, α-tubulin and β-actin were used as a loading control to normalize the levels of protein 
detected by confirming that protein loading is the same across the gel. The expression of CD14 
and MARCO were confirmed based on the presence of a protein band corresponding to the 
expected molecular weight. CD14 was detected at 55kDa, and MARCO was detected at 68kDa, 











Figure 3.5: Semi-quantitative analysis of the expression of total CD14 and MARCO in 
JEG-3 cells. 
Western blot of JEG-3cells using MEM-18 (anti-CD14), 2G12 (anti-MARCO), and TU-02 (anti-
alpha-subunit tubulin) monoclonal antibodies (mAb).MEM-18 is specific for CD14 53-55 kDa,  
2G12  is specific for MARCO 68 kDa,Poly6221 detects β-actin, which was detected at a 
molecular weight of 42 kDa, and TU-02 detects full length α-tubulin. Anti β-actin and antiα-
tubulin were used as loading control. A protein band for MARCO was expected to be detected at 
68 kDa, and was detected in JEG-3 cells, using the Raji and THP-1 cell line as a positive control. 
The presence of bands corresponding to the expected molecular weight of CD14 confirmed that 
JEG-3 cells express CD14, compared to the Raji and THP-1cell line used as a positive control. 
CD14 was expected to be detected between 53-55 kDa.  
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3.2.5 Confocal microscopy 
 
Confocal immunofleorescence microscopy was performed in order to obtain graphical evidence 
of the expression of CD14 and MARCO receptors on JEG-3 cells. To the author's knowledge, 
the expression of CD14 and MARCO on JEG-3 cells has not been previously studied. THP-I 
cells were used as a positive control for CD14 and MARCO cell-surface expression, since the 
two molecules in these cells have been widely studied. 
The negative control cells stained with IgG isotype conjugated with either green AF488 or red 
AF555 secondary antibody, where the blue colour is DAPI stained nucleus (Fig. 3.6). In the 
images, no signals above background fluorescence were observed thus indicating no false 
positive signals were detected, furthermore, the morphology of the nucleus indicates that the 
cells observed are in a healthy state.  
Cell surface expression of CD14 receptors on JEG-3 and THP1 cells was visualised by laser 
scanning confocal microscope (Fig. 3.7). Green fluorescence on both cell lines represents the 
CD14 receptor expression, where these receptors are uniformly distributed all over the cells. 
Blue coloured nucleus and differential interference (DIC) images represent the cell health 
morphology. 
Microscopic analysis of MARCO receptor expression in test cell line JEG-3 and in positive 
control THP1 cell line is shown in figure 3.8. Micrograph of THP1 cell indicates that MARCO 
receptors are uniformly distribute all over the cell surface, whereas, on JEG-3 cells MARCO 
receptors are mostly concentrated on Polar Regions. Nucleus and DIC images confirm good cell 






Figure 3.6 Confocal microscopy images of JEG-3 and THP-1 cells as isotype-negative 
controls. 
The isotype control comprised cells stained with isotype control IgG primary and Alexa Fluor® 
488 and Alexa Fluor® 555 secondary antibodies. Fluorophores were excited using green 488 nm 
and red 555 nm wavelength lasers and used to measure non-specific antibody binding. Blue 
colour shows DAPI stained cell nuclei, red and green show the merged image, whereas DIC is 






Figure 3.7: Cell-surface staining of CD14 onJEG-3 and THP-1 cells as visualised by 
confocal laser scanning microscopy. 
JEG-3and THP-1 cells were cultured in LabTek 8-well chambers at a density of 3x 10
3
 cells per 
well overnight. Cells were stained with CD14 labelled with Alexa Fluor® 488 (green). Cell 
nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI), which is shown in blue. 






Figure 3.8: Cell-surface staining of MARCO expressed in JEG-3 and THP-1 cells as 
visualised by confocal laser scanning microscopy. 
JEG-3 and THP-1 cells were cultured in LabTek 8-well chambers at a density of 3x 10
3
 cells per 
well overnight. Cells were stained with Alexa Fluor® 555 (red), cell nuclei were stained with 4', 
6-diamidino-2-phenylindole (DAPI), which is shown in blue. Photomicrographs are 





3.2.6 Colocalisation analysis 
 
Colocalisation analysis has been performed to estimate that whether CD14 and Marco receptors 
are closely associated and interacting each other. For this purpose, firstly, JEG-3 and THP1 cells 
were double stained for MARCO and CD14 receptors. Cells were then imaged by laser scanning 
confocal microscope at single cell level using sequential scanning for each wavelength, which 
avoids bleed through between red and green channels. In the micrograph, green colour represents 
CD14; red colour represents MARCO, whereas yellow colour in merged images indicates close 
association of MARCO and CD14 receptors (Fig. 3.9). 
 In this study, two different methods to measure the colocalisation have been employed. 
a) Pearson’s correlation coefficient for colocalisation 
b) Sparse colocalisation 
3.2.6a. Pearson’s correlation coefficient for colocalisation 
 
Pearson’s correlation coefficient (PCC) for colocalisation was performed by using Colocalisation 
threshold plugin in ImageJ with auto threshold settings. Three dimensional microscopic images 
were used for the analysis and value of PCC indicates the correlation between CD14 and 
MARCO receptors. Composites of merged red and green channels and their scatter plots are 
shown in figure 3.10. In THP1 cell line PCC value is 0.925, thus indicating strong positive 
correlation between CD14 and MARCO receptors. In JEG-3 cells, PCC value is 0.737, thus 







Figure 3.9: Colocalisation of CD14 and MARCO on the cell-surface of JEG-3 cells. 
Colocalisation of CD14 and MARCO on the cell-surface of JEG-3 cells and THP-1 is shown. 
JEG-3 cells and THP-1 were double stained with CD14 primary antibody labelled with (FITC) 
Alexa Fluor® 488 (green) or with MARCO primary antibody labelled with (TRITC) Alexa 
Fluor® 555 (red). Yellow fluorescence in the merged green and red channels indicates the close 
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Figure 3.10: Pearson’s correlation coefficient (PCC) for colocalisation. 
Left column represents composites for red and green merged images. Right column shows 2D 
scatter plot for colocalised red and green receptors, white diagonal line is best fit for the 
regression. 
 




3.2.6b. Sparse colocalisation 
Sparse colocalisation is an object based quantitative method to estimate the colocalisation of 
proteins understudy. The cells were immunofluorescent double stained for CD14 and MARCO 
receptors and three dimensional sequentially scanned images were taken for each wavelength at 
single-cell level. Cell surface receptors appear as green and red spots in the image (Figure 3.11). 
Confocal microscopic images of immune receptors tagged with antibodies appeared as masses of 
spherical blurred spots distributed all over the cell surface. In this study, antibody-labelled 
surface receptors were imaged separately at different wavelengths, resulting as diffraction-
limited isotropic spots of uniform size in each channel. As the resolution is poorer in axial (z) 
direction than laterally (xy), the three dimensional (3D) receptors appear as cigar-shaped (Figure 
3.11). In this study, CD14 receptors are seen as green spots and MARCO receptors as red spots, 
while yellow spots represent co-expressed CD14 and Marco receptors. In each cell image, the 
blue colour represents DAPI stained nucleus (Figure 3.11). 
For colocalisation analysis, 3D single cell images were first separated for each channel, 
represented as channel 1 (CD14 receptors) and channel 2 (Marco receptors). Receptors from 
each channel with varying fluorescent intensity and high background noise were robustly 
identified by the algorithm. Receptors in channel 1 and channel 2 are identified as green spots 
and quantified as number of receptors expressed on one cell (Figure 3.12A & B). Identified and 
quantified green spots in the figure 3.12A represent 229 CD14 receptors, while in figure 3.12B 
are 83 MARCO receptors. 
For identified receptor in each channel, the colocalisation algorithm determines the centre of 
each ellipsoid, even if they vary considerably in fluorescent intensity and background noise. The 
radius of each identified spot and level of background noise is determined by the algorithm. Two 




not exceed the user-defined parameter d which is 200nm, the maximum colocalisation distance 
between the centres. A 3D colocalisation scatter plot is shown in figure 3.13, where green 
asterisks represent CD14 receptors, red asterisks reflect MARCO receptors, and blue encircled 
red green asterisks are colocalised MARCO and CD14 receptors. 
Sparse colocalisation provided quantitative data for number of colocalised receptors along with 
distances between centres of two colocalised receptors which are represented in a 3D distance 
plot (Fig. 3.14). Colour coded distance bar ranging from 20-200nm corresponds to the distance 
between colocalised receptors (Fig. 3.14 A), and histogram shows frequency of colocalised 










Figure 3.11: Colocalisation of CD14 and MARCO on the cell-surface of JEG-3 cells. 
JEG-3 cells and THP-1 cells were cultured in LabTek 8-well chambers at a density of 6x 10
3
cells 
per well overnight. Colocalisation of CD14 and MARCO on the cell-surface of JEG-3 cells is 
shown. JEG-3 cells were double stained with CD14 primary antibody labelled with (FITC) 
Alexa Fluor® 488 (green) or with MARCO primary antibody labelled with (TRITC) Alexa 
Fluor® 555 (red). Colocalisation is shown as yellow fluorescence, the result of merging green 
and red channels; highly colocalised area of CD14 and MARCO is shown. 3D image was used to 











Figure 3.12: Projection images from each channel for sparse colocalisation. 
A- Channel 1 represents CD 14 where green spots represent identified and quantified CD14 
receptors. B- Channel 2 represents MARCO where green spots represent identified and 













Figure 3.13: Colocalisation 3D scatter plot. 
  
Green asterisks represent CD14 receptors, red asterisks show MARCO receptors, and blue 






















Figure 3.14: Colocalisation distance plot and distance histogram 
A. 3D distance plot for colocalised CD14 and MARCO receptors, where coloured bar 
code represents distance between colocalised receptors. B. A histogram graph for 







Firstly, this study has identified the phenotyping of CD14 and MARCO receptors in JEG-3 
choriocarcinoma first trimester trophoblast cells by using flow cytometry, immunoblot analysis 
and microscopy imaging. CD14 expression has previously been confirmed in monocytes and 
macrophages (Daigneault, et al., 2010).  
MARCO has also not been previously reported to be expressed on trophoblast cells. Human 
MARCO expression is most robust in the liver, lymph nodes, monocytes and alveolar 
macrophage, and is mainly involved in the filtration of blood and lymph fluids (Jozefowski et al., 
2005). 
Secondly, the study detected and quantified the biological interaction of CD14 and MARCO 
receptors on JEG-3 cells by colocalisation analysis. Further investigation is required to confirm 







Chapter 4  
Cell surfaceCD14 and macrophage scavenger receptor MARCO expression 
on cytotrophoblastic JEG-3 cells after LPS exposure  
4.1. Introduction 
The feto-maternal interface system has two major roles: promoting the growth and development 
of the placenta and the maintenance of immunological tolerance and surveillance. Equilibrium 
must be maintained between them; an imbalance can result in clinical complications such as 
preeclampsia and pre term labour. Placental cells, particularly trophoblast cells, and classical 
immune cells (macrophages, natural killer cells, etc.) all have a role in immune surveillance at 
the maternal-fetal interface. 
Foreign pathogens are detected through receptors present on macrophages, known as pattern-
recognition-receptors (PRRs). PRRs include Toll-like receptors (TLR), cluster of differentiation 
(CD) 14 and scavenger receptors (Sankala et al., 2002). PRRs recognize and bind to pathogen-
associated molecular pattern (PAMP) molecules that are associated with groups of pathogens, 
which results in an immunosurveillance response against invading pathogens (Koga et al., 2010). 
Lipopolysaccharide (LPS), a prototypical PAMP present on the outer membrane of Gram-
negative bacteria, is recognized by TLR-4. LPS is a very effective activator of innate immunity, 
as its lipophillic component and polysaccharide polymer are covalently linked to the membrane-
anchor domain in  the bacterial outer membrane (Sankala et al., 2002). 
CD14, together with TLR-4 and lymphocyte antigen 96 (LY96, or MD-2) acts as a co-receptor 
for the detection of LPS. CD14 is a 55kDa glycoprotein which is initially processed in the 
endoplasmic reticulum and then expressed on the cell surface (Gegner et al., 1995). The protein 
is composed of 375 amino acids and it contains leucin-rich repeats which are significant in 




(GPI)-anchored membrane protein (mCD14) on monocytes and solubleCD14 (sCD14) in plasma 
(Heidenreich 1999).  
Scavenger receptors constitute a family of immunosurveillance receptors. They have been 
categorised into different subclasses according to their tertiary structure (Thelen et al., 2010). 
Class A scavenger receptors (SR-As) are a collection of pattern-recognition receptors, and 
include SR-AI/II, macrophage receptor with collagenous structure (MARCO), scavenger 
receptor with C-type lectin, and scavenger receptor class A, member 5 (Arredouani et al., 2006). 
MARCO is suggested to play a role in antimicrobial defence, as indicated by its up-regulation in 
macrophages during bacterial infections in the liver and spleen (Arredouani et al., 2004). The 
majority of murine MARCO is expressed by marginal zone macrophages in the spleen, by 
macrophages of the medullary cord in lymph nodes and by peritoneal macrophages (Granucci et 
al., 2003). The expression of human MARCO is detected to be most robust in the liver, lymph 
nodes, and monocytes which are involved in the filtration of blood and lymph fluids (Jozefowski 
et al., 2005). 
This part of in-vitro study is focused on the regulation of CD14 and MARCO receptors upon 
LPS treatment and also to further study the effect of LPS on their biological association in JEG-3 
cells. 
AIM OF STUDY 
 To investigate the regulation of CD14 and MARCO receptors upon LPS treatment in 
time and dose dependent manner. 






4.2.1 Surface CD14 expression on JEG-3 cells following LPS exposure 
Flow cytometry analysis of cell surface CD14 was performed on THP-1leukemia cells, and 
untreated and LPS-treated JEG-3 cells. Cells were treated with LPS in a time and dose-
dependent manner. The cells were stained with an appropriate concentration of the primary 
antibody CD14 (MEM-18) followed by secondary antibody anti-mouse IgG FITC. Unstained 
cells and isotype cells stained with only the secondary antibody were used as a negative control. 
Untreated THP-1 cells were used as the positive control.  
Flow cytometric analysis of CD14 expression upon time and dose dependent LPS treatment is 
presented in figure 4.1, where expression of CD14 increased with increasing LPS concentrations 
and increasing incubation times. This effect can be observed by shifting of empty histogram on 
log scale x-axis from left to right, as compared to dark filled histogram representing isotype 
control. The highest expression of CD14 was detected in JEG-3 cells treated with 20 µg/ml of 
LPS for 12 hours. 
Graphical representation of MFI values for CD14 expression is plotted against LPS dose and 
incubation times in figure 4.2. The graph reflects that CD14 receptors were up regulated with the 








Figure 4.1: Flow cytometric analysis of surface expression of CD14 by JEG-3 cells 
following time and dose dependent LPS exposure. 
JEG-3 cells were cultured in the presence of LPS (1, 10 and 20 ug/ml) for 12 hrs, 24 hrs and 48 
hrs. Empty histograms represent the expression of CD14 whereas black-filled histograms show 









































































































































































































































































































Figure 4.2: Graphical representation of CD14 surface expression in untreated JEG-3 and 
LPS-treated JEG-3 cells. 
Mean fluorescence intensity values were measured based on geometric means. Grey bars 
represent cell-surface expression of CD14 in untreated and LPS treated JEG-3 cells.  ± SD in 
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4.2.2 Cell surface expression of MARCO on JEG-3 cells after LPS exposure 
Flow cytometry analysis of cell surface MARCO was performed on untreated and LPS-treated 
JEG-3 cells. Cells were treated with LPS in a time and dose-dependent manner. The cells were 
stained with an appropriate concentration of anti-MARCO antibody (clone 2G12), followed by 
FITC-conjugated secondary antibody. Unstained cells and isotype cells stained with only the 
secondary antibody were used as a negative control  
The results show that the expression of MARCO decreased significantly when JEG-3 cells were 
treated with LPS in the range of 1, 10, and 20 µg/ml of LPS for a period of 12, 24 and 48 hours 
(Figure 4.3). The highest expression of MARCO was detected in untreated JEG-3 cells whereas, 
MARCO receptor expression significantly declined upon LPS treatment in both time and dose 
dependent manner. 
The geometric mean values of MFI for MARCO expression are graphically presented against 
each treatment group in figure 4.4, which indicates continuous down regulation of this receptor 









Figure 4.3: Flow cytometric analysis of surface expression of MARCO byJEG-3 cells after 
LPS exposure. 
JEG-3 cells were cultured in the presence of LPS (1, 10 and 20 ug/ml) for 12 hrs, 24 hrs and 48 
hrs. Empty histograms represent the expression of MARCO on untreated JEG-3and LPS treated 
JEG-3 cells, whereas black filled histograms show negative controls. Data are representative of 









 P  
 g ml 
2  hr 
 P  
 g ml 
   hr 
Cells onl                    1  g                           10  g                      20 



























































































































































































 P  








































































Figure 4.4: Graphical representation of MARCO surface expression in untreated JEG-3 
and LPS treated JEG-3 cells. 
Bar graphs represent the level of MARCO expression in mean values ± SD in each cell line. 
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4.2.3 Immunoblot analysis of the effect of LPS on CD14 expression in JEG-3 cells 
Western blot analysis was performed in order to investigate CD14 protein expression in    JEG-3 
cells after LPS exposure. Cell lysates were prepared from JEG-3 cells cultured in the presence of 
different concentrations of LPS: 1, 10, 20 µg/ml for 12, 24 and 48 hours. β-actin was used as a 
loading control to normalise the amount of total protein loaded across the gel. The presence of a 
55kDa protein band confirmed the expression of CD14 in JEG-3 cells (Fig. 4.5A). Differential 
expression of CD14 was observed with increased CD14 expression upon increasing time and 
LPS doses. The graphical representation of densitometry analysis (Fig. 4.5B) also confirmed the 








Figure 4.5: CD14 expression by western blot analysis in LPS-treated JEG-3 cell line. 
 (A) SDS-PAGE (12%) was performed under reducing conditions, followed by Western blotting 
with primary monoclonal antibodies Poly6221(anti β-actin as loading control) and anti-CD14. β-
actin was detected at a molecular weight of 42kDa. The 53-55kDa band that corresponds to 
CD14 was observed. (B) Relative levels of MARCO in LPS-treated JEG-3 cells. CD14 levels 
are normalized against β-actin to account for the difference in protein loading during the 
experiment. The percentage of regulation was calculated after the intensity of each band was 
adjusted according to its respective β-actin band intensity using Image Studio Lite software (LI-
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4.2.4 Immunoblot analysis of the effect of LPS on MARCO expression in JEG-3 cells  
Western blot analysis was performed in order to investigate MARCO protein expression in    
JEG-3 cells after LPS exposure. Whole cell lysates were prepared from JEG-3 cells cultured in 
the presence of different concentrations of LPS: 1, 10, and 20 µg/ml for 12, 24 and 48 hours. α-
tubulin was used as a loading control to normalise the amount of total protein loaded across the 
gel. The presence of a 68 kDa protein band confirmed the expression of MARCO in   JEG-3 
cells (Fig. 4.6A). Differential expression of MARCO was observed with decreased MARCO 
expression upon increasing incubation times and LPS doses. The graphical representation of 
densitometry analysis (Fig. 4.6B) also confirmed the similar pattern of CD14 expression. Thus, 








Figure 4.6: MARCO expression by western blot analysis in LPS-treated JEG-3 cell line. 
 (A) SDS-PAGE (12%) was performed under reducing conditions, followed by Western blotting 
with primary monoclonal antibodies TU-02 (anti α-Tubulin as loading control) and anti-
MARCO. α-tubulin was detected at a molecular weight of 55 kDa. The 68 kDa band 
corresponds to MARCO protein. (B) Relative levels of MARCO in LPS-treated JEG-3 cells. 
MARCO levels are normalized against α-tubulin to account for the difference in protein loading 
during the experiment. The percentage of regulation was calculated after the intensity of each 
band was adjusted according to its respective α-tubulin band intensity using Image Studio Lite 
software (LI-COR Biosciences). Comparison of MARCO expression in untreated and LPS-
treated JEG-3 cells was assessed using densitometry analysis. A representative immunoblot of 
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4.2.5 Confocal microscopy  analysis of CD14 and MARCO  
Confocal immunofluroscence microscopy was performed to obtain graphical evidence for the 
expression of CD14 and MARCO receptors on JEG-3 cells incubated with 1, 10 and 20 µg/ml 
LPS concentrations at 12 hours (Fig. 4.7), 24 hours (Fig. 4.8) and 48 hours (Fig 4.9) time points.. 
In each micrograph, green colour indicates CD14, and red colour represents MARCO receptors. 
Colocalisation of MARCO and CD14 receptors in each treatment condition was calculated by 
measuring Pearson correlation coefficient, where PCC values are provided under PCC column 
next to each micrograph. The general trend observed in this data was, MARCO and CD14 
receptor colocalisation was decreased with increasing LPS doses and increased incubation times. 
At 12 and 24 hour time points, there is no significant difference in PCC values between different 
LPS concentrations, whereas, at 48 hour time point PCC values decreased with increasing LPS 
concentration. Thus considering aforementioned trends in CD14 and MARCO expression in 
response to LPS, the decreased colocalisation could be due to decreased MARCO expression and 








Figure 4.7: Colocalisation of CD14 and MARCO receptors on JEG-3 cells at 12 hours. 
(Objective x60). 
JEG-3 cells were cultured in LabTek 8-well chambers at a density of 8 x 10
3 
cells per well. JEG-
3 cells were treated with LPS (1µg/ml, 10µg/ml, 20µg/ml,) for 12 hours. The area of 
colocalisation is indicated by merged images of the individual receptors. Highly colocalised 
areas between CD14 and MARCO are indicated in yellow. Pearson correlation coefficient (PCC) 
was used to analyse the percent of colocalisation. 
 
  



















































Figure 4.8: Colocalisation of CD14 and MARCO receptors on JEG-3 cells at 24 hours. 
(Objective x60). 
JEG-3 cells were cultured in LabTek 8-well chambers at a density of 8 x 10
3 
cells per well. JEG-
3 cells were treated with LPS (1µg/ml, 10µg/ml, 20µg/ml,) for 24 hours. The area of 
colocalisation is indicated by merged images of the individual receptors. Highly colocalised 
areas between CD14 and MARCO are indicated in yellow. Pearson correlation coefficient (PCC) 








Figure 4.9: Colocalisation of CD14 and MARCO receptors on JEG-3 cells at 48 hours. 
(Objective x60). 
JEG-3 cells were cultured in LabTek 8-well chambers at a density of 8 x 10
3 
cells per well. JEG-
3 cells were treated with LPS (1µg/ml, 10µg/ml, 20µg/ml,) for 48 hours. The area of 
colocalisation is indicated by merged images of the individual receptors. Highly colocalised 
areas between CD14 and MARCO are indicated in yellow. Pearson correlation coefficient (PCC) 
was used to analyse the percent of colocalisation. 
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This part of study has investigated surface CD14 and MARCO expression on JEG-3 cells 
following their exposure to LPS in time and dose dependent manner. The results of the flow 
cytometric and immunoblot analyses showed that surface expression of CD14 is increased upon 
treatment with different concentrations of LPS for different periods of time. In contrast to CD14, 
MARCO expression was down regulated upon increasing LPS doses and treatment times. 
Biological interaction of MARCO and CD14 receptors was unaffected at 12 and 24 hours for all 
three concentrations, but was decreased at 48 hours with increasing LPS concentration. This 
phenomenon could be due to decreased MARCO to CD14 receptors ratio. Further investigations 








 Analysis of cell proliferation, Myoferlin and VEGF expression and NF-κB on 
the human choriocarcinoma cell line JEG-3 in response to Lipopolysaccharide 
5.1 Introduction 
In an attempt to investigate the molecular effects resulting from trophoblast infections, a part of 
this study was focused on trophoblast cell proliferation and activation of the nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB) activation. Cell proliferation is a crucial 
factor for the immune system. It is also essential for extravillous trophoblast (EVT) cells, 
contributing to embryo implantation, invasion into the maternal uterine wall and a successful 
pregnancy.  
Myoferlin is a protein associated with the stability and function of the vascular endothelial 
growth factor (VEGF) receptor 2 (Bernatchez et al., 2007). Its reduced expression can be a 
reason for reduced cell proliferation. The effect of LPS on Myoferlin on trophoblast cells has not 
been elucidated.  
NF-κB is a protein complex that regulates DNA transcription. NF-κB is involved in several 
cellular responses against a range of stimuli including LPS stimulation from bacterial infection, 
cytokines and viral antigens (Gilmore, 2006). NF-κB is therefore a crucial factor in regulating 
the immune response to infection. The role of NF-κB in regulating transcription on trophoblast 
cells has not been addressed. It is reasonable to assume that incorrect regulation of NF-κB would 
influence the function of trophoblast cells during pregnancy. In non-pregnant settings NF-κB has 
been linked to inflammatory and autoimmune diseases, septic shock, viral infection, and 
improper immune development (Perkins, 2007).  




signal via both MyD88-dependent and -independent pathways (Akira and Hoshino, 2003) and 
provoke first trimester trophoblast cells to produce high levels of cytokines, includingIL-2, IL-6, 
TNF-α and IFN-γ (Abrahams et al., 2004).  These studies highlight the sensitivity of trophoblast 
cells multiple cytokines. Interestingly, placental expression of IFN-γ and TNF-α has been 
associated with trophoblast cell apoptosis (Aschkenazi et al., 2002; Yui et al., 1994). Thus, 
regulation of the cytokine repertoire during pregnancy is of pivotal importance.  
In this section of the project the expression profile of Myoferlin and VEGF antigens on JEG-3 
cells and their role in cell proliferation was examined in response to LPS. Furthermore, cell 
proliferation and NF-κB activation assays were performed to investigate the effect of LPS on 






5.2.1 Myoferlin analysis in JEG-3 cells  
Flow cytometry analysis of Myoferlin expression was performed on untreated and LPS-treated 
JEG-3 cells as explained in section 2.2.2. Cells were treated with LPS in a time and dose-
dependent manner. The cells were stained with an appropriate concentration of the primary 
antibody (FER1L3) specific for Myoferlin followed by secondary antibody (RAM-FITC). JEG-3 
cells were incubated with 1, 10 and 20 g/ml of LPS for 12, 24 and 48 hours. Unstained cells 
and cells stained with only the secondary antibody were used as a negative control.  
Moderate level of expression of Myoferlin on the plasma membrane was observed, in the 
untreated JEG-3 cells (Fig 5.1 A). Myoferlin expression was down-regulated following treatment 
with LPS in both the dose 1, 10, 20, µg/ml and time 12, 24 and 48 hours, dependent manner 
(Figure 5.1 B). The decrease in the flow cytometry histogram can be observed by shift of dotted 
line histogram towards left, more towards negative control isotype solid line histogram, thus 
indicating decrease in the mean fluorescent intensity of myoferlin. The lowest expression of 
myoferlin was detected in JEG-3 cells treated with 20 µg/ml of LPS at all time points. JEG-3 
cells treated with 20 µg/ml of LPS for 48 hours showed the least expression of Myoferlin (Fig. 
5.1 B). 
Myoferlin expression levels are also presented quantitatively in the bar graph (Fig. 5.2), where 
MFI is plotted against LPS treatment conditions. The decrease in MFI (grey bars) indicates that 
the expression of Myoferlin was down-regulated after exposing the cells to LPS. Down 
















Figure 5.1. Flow cytometry analysis of surface expression of Myoferlin (FER1L3) 
JEG-3 cells were cultured in the presence of different concentrations of LPS (1, 10 and 20 
µg/ml) for 12, 24and 48 hrs. Dotted outlined histograms represent the expression of Myoferlin 
on untreated and LPS treated JEG-3 cells, whereas straight outlined histograms show negative 
controls. Cells were labelled with a FITC-conjugated secondary anti-mouse antibody. Data is 
















Figure 5.2. Quantitative representation of Myoferlin surface expression in untreated JEG-3 
and LPS treated JEG-3 cells. 
Myoferlin expression levels on JEG-3 cells were analysed on a BD Accuri flow cytometer and 
FlowJo 8.8.6 software. Mean fluorescence intensity values were measured based on geometric 
means. Grey bars represent cell-surface expression of Myoferlin in untreated and LPS treated 
JEG-3 cells. Bar graphs represent the level of Myoferlin expression in mean values ± SD. Data 
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5.2.2 VEGFR-2analysis in JEG-3 cells  
Flow cytometry analysis of VEGFR-2 expression was performed on untreated and LPS-treated 
JEG-3 cells in a time and dose-dependent manner. The cells were stained with an appropriate 
concentration of the primary antibody VEGFR-2 followed by secondary antibody anti-mouse 
IgG FITC. Unstained cells and cells stained with only the secondary antibody were used as a 
negative control. Untreated JEG-3 cells were used as the positive control or reference group. 
Analysis of the data revealed moderate to weak level of expression of VEGFR-2 receptors on 
JEG-3 cells in comparison to the isotype negative control (Fig. 5.3 A). The expression of 
VEGFR-2 decreased when treated with LPS in a dose and time dependent manner (Fig 5.3 B). 
The decrease in the flow cytometry histogram can be observed by shift of dotted line histogram 
towards left, more towards negative control isotype grey filled histogram, thus indicating 
decrease in the mean fluorescent intensity of VEGFR-2. Like aforementioned myoferlin data in 
section 5.2.1, the lowest expression of VEGFR-2 was noticed in JEG-3 cells treated with 20 
µg/ml of LPS for all time points. JEG-3 cells treated with 20 µg/ml of LPS for 48 hours showed 
the least expression of VEGFR-2 (Fig. 5.3 B). 
VEGFR-2 expression levels are also presented quantitatively in the bar graph (Fig. 5.4), where 
MFI is plotted against LPS treatment conditions. The decrease in MFI (grey bars) indicates that 
the expression of VEGFR-2 was down-regulated after exposing the cells to LPS. Down 













Figure 5.3. Flow cytometry analysis of surface expression of VEGFR-2 by JEG-3 cells 
following LPS exposure. 
JEG-3 cells were cultured in the presence of the indicated concentrations of LPS (1, 10 and 20 
ug/ml) for 12, 24 and 48 hrs. Empty histograms represent the expression of VEGFR-2on 
untreated JEG-3 and LPS treated JEG-3 cells, whereas grey histograms show negative controls. 




















Figure 5.4. Quantitative representation of VEGFR-2 surface expression in untreated JEG-
3 and LPS treated JEG-3 cells. 
 
 
VEGFR-2 expression levels on JEG-3 cells were analyzed on a BD Accuri flow cytometer and 
FlowJo 8.8.6 software. Mean fluorescence intensity values were measured based on geometric 
means. Grey bars represent cell-surface expression of VEGFR-2 in untreated and LPS treated 
JEG-3 cells. Bar graphs represent the level of VEGFR-2 expression in mean values ± SD. Data 
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5.2.3 Immunoblot analysis of Myoferlin and VEGF 
Western blot analysis was performed to investigate Myoferlin and VEGF expression in   JEG-3 
cells following LPS stimulation. Cell lysate were prepared from JEG-3 cells cultured in the 
presence of LPS of different concentrations: 1, 10, 20 µg/ml for 12, 24 and 48 hours, and 
untreated control group for each time point, used as reference. Heat Shock Protein 90 (Hsp 90) 
was used as a loading control to access the equal loading of total protein across the gel. 
The presence of a 210 kDa band confirmed expression of myoferlin in JEG-3 cells (Fig. 5.5 A). 
The results show slight but steady decrease in the expression of myoferlin in the whole cell 
lysate, with increasing LPS concentrations and incubation times, and in comparison to untreated 
reference group. Thus, these results indicate that LPS down-regulates the expression of myofelin 
in JEG-3 trophoblast cells.  
In case of VEGF, three isoforms have been detected at molecular weights 40, 46 and 55 kDa 
(Fig. 5.5 B). No significant difference in the VEGF isoform bands has been detected across LPS 
concentrations at 12 hour time, but at 24 and 48 hour time points a very noticeable difference in 
the VEGF bands are observed across the LPS doses, where VEGF bands are weaker with 
increasing LPS doses as compared to untreated reference group. At 48 hours incubation times, 
VEGF bands are very faint along with increasing LPS concentrations, and in comparison to 
untreated reference group. Thus, these results identified that VEGF and myofelin expression in 









Figure 5.5: Characterization of the expression of Myoferlin and VEGF in untreated and 
LPS-treated JEG-3 cells. 
Western blot analysis of Myoferlin (FER1L3) and VEGF (A-20) in JEG-3 cells whole lysates 
from untreated and LPS treated JEG-3 cells in time and dose dependent manner. A: Myoferlin 
(FER1L3) was detected at a molecular weight of 210 kDa. B: Levels of VEGF (A-20) were 
detected for VEGF isoforms at a molecular weights 55, 46, 40 kDa. Hsp 90 (Heat Shock Protein 
90) was used as loading control in both A and B. The figures are representative of three 





5.2.4 Analysis of Myoferlin by Confocal microscopy 
Confocal immunofluroscence  microscopy was performed to further examine the expression of 
Myoferlin receptors on JEG-3 cells and visualize their topographical distribution. Cells without 
staining and isotype cells, stained with only secondary antibody, were used as a negative control, 
which did not show cell autofluorescence or non-specific binding to the cells (data not shown 
here). The DAPI stained blue nucleus indicates the cells observed are in a healthy state. Confocal 
microscopic images of LPS treated JEG-3 cells in time and dose dependent manner have been 
presented as 1, 10, and 20 µg/ml LPS at 12 hours (Fig. 5.6), at 24 hours (Fig. 5.7), and at 48 
hours (Fig. 5.8). The expression of Myoferlin decreased over time in response to LPS. This 
indicates that LPS has a regulatory effect on the expression of Myoferlin on trophoblast cells and 



















Figure 5.6: Time-dependent modulation of Myoferlin on JEG-3 cells in response to 12 hr 
treatment with LPS as visualised by confocal laser scanning microscopy. 
Cells were stained with the Myoferlin specific antibody (FER1L3) labelled with Alexa Fluor® 
555 (red), cell nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI), which is shown 












Figure 5.7: Time-dependent modulation of Myoferlin on JEG-3 cells in response to 24 hr 
treatment with LPS as visualised by confocal laser scanning microscopy. 
Cells were stained with the Myoferlin specific antibody (FER1L3) labelled with Alexa Fluor® 
555 (red), cell nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI), which is shown 







Figure 5.8: Time-dependent modulation of Myoferlin on JEG-3 cells in response to 48 hr 
with LPS as visualised by confocal laser scanning microscopy. 
Cells were stained with the Myoferlin specific antibody (FER1L3) labelled with Alexa Fluor® 
555 (red), cell nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI), which is shown 





5.2.5 Analysis of VEGF by Confocal microscopy  
The VEGF receptor expression was studied through confocal immunofluroscence  microscopy to 
further examine the expression of on JEG-3 cells and visualized their topographical distribution. 
Cells without staining and isotype cells, stained with only secondary antibody, were used as a 
negative control where no cell autofluorescence or non-specific antibody binding was observed 
(data not shown here). 
Confocal microscopic images of untreated and LPS (20 µg/ml) treated JEG-3 cells are shown in 
figure and cells treated with LPS for a period of 12, 24 and 48 hours. The expression of VEGF 
decreased over time in response to LPS in both time and dose-dependent manner (Figure 5.2.9). 
This indicates that LPS has a regulatory effect on the expression of VEGF on trophoblast cells 



























Figure 5.9: Time-dependent modulation of VEGF on JEG-3 cells in response to LPS as 
visualised by confocal laser scanning microscopy. 
Cells were stained with the VEGF specific antibody (FER1L3) labelled with Alexa Fluor® 555 
(red), cell nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI), which is shown in 



























   LPS 
20ug/ml 
   12hr 




   LPS 
20ug/ml 
   24hr 





    LPS 
20ug/ml 
   48hr 




5.2.6TrophoblastCell Proliferation Assay in response to LPS 
Proliferation of trophoblast cells upon exposure to LPS was studied in dose and time dependent 
manner. JEG-3 cells were treated with varying concentrations of LPS (1, 10 and 20 g/ml) for 
12, 24 and 48 hours. Untreated cells were used as a positive control and Camptothecin (CPT) a 
cytotoxin served as a negative control. Results from time dependent effect of LPS treatments on 
JEG-3 cells are presented in figure 5.10, where cells were incubated with 20 µg/ml LPS for 12, 
24 and 48 hours.  
The results indicate that at 12 hours of treatment, JEG-3 cells showed ~70% viable cells in 
response to LPS resulting in a decrease in the growth rate as compared to untreated cells, but 
similar to negative control CPT (Figure. 5.10). At 24 hours, cell viability significantly decreased 
to ~55% as compared to untreated reference group, whereas at 48 hour treatment, cell growth of 
treated cells rapidly decreased to ~20% as compared to untreated cells, thus the same growth 
pattern was followed as CPT treated cells (Figure 5.10). Therefore, time dependent LPS effect 
appeared to cause very significant damage to trophoblast cell survival. 
Dose dependent effect of LPS treatments on JEG-3 cells are presented in figure 5.11. Treated 
JEG-3 cells were incubated with 1, 10 and 20 µg/ml LPS for 24 hours. The results indicated that 
at 24 hours of treatment with 1 µg/ml LPS, JEG-3 cells did not show significant difference on 
cell viability as compared to control. Whereas, 10, and 20 µg/ml LPS showed a steady decrease 
(85% and 75% respectively) in cell viability as compared untreated group. Thus, results of 
proliferation assay indicate that LPS presence can activate some signalling pathway in the JEG-3 










Figure 5.10: Cell proliferation assay of JEG-3 cells in response to time dependent bacterial 
LPS. 
JEG-3 cells were seeded in 96 well-plates and treated with indicated concentrations of LPS. The 
values on ordinate represent corrected percentage cell viability ± SD of quadruplicate samples. 
Abscissa illustrates time points of each observation taken for cell growth under specified 
conditions. Untreated cells were used as a positive control while CPT-camptothecin was served 






























Figure 5.11: Cell proliferation assay of JEG-3 cells in response to dose dependent LPS 
treatments. 
JEG-3 cells were seeded in 96 well-plates and treated with indicated concentrations of LPS. The 
values on ordinate represent corrected mean percentage cell viability ± SD of quadruplicate 
samples. Abscissa illustrates time points of each observation taken for cell growth under 
specified conditions. Untreated cells were used as a positive control while CPT-camptothecin 


























5.2.7 Effect of LPS on NF-κB activation in trophoblast JEG-3 cells  
Effect of LPS was examined on NF-κB activation in JEG-3 cell when cells were incubated with 
20 µg/ml LPS for 12, 24 and 48 hours. NF- κB activation was investigated by microscopy 
followed by colocalisation analysis for localisation of NF-κB p65 in trophoblast cell nucleus in 
response to LPS (Fig. 5.12). 
Micrographs of JEG-3 cells show distribution of NF-κB in the cytoplasm (red colour) of all 
untreated and treated cells but no detectable amount of NF-κB can be seen inside the nucleus 
(blue colour) in the control and 12h LPS treated cells (Fig. 5.12). However, the distribution of 
NF-κB (red colour) in the nucleus (blue colour) in 24h treated cells increased. The same pattern 
was followed resulting in a significant increase in the distribution of NF-κB (red colour) in the 
nucleus (blue colour) of 48hr h LPS treated cells Thus suggesting that NF-κB activation in 
trophoblast cells occur after the first 24 hours of LPS incubation.  
In order to further investigate the localisation of NF-κB inside the nucleus, colocalisation of NF-
κB and nuclear DNA was performed by using colocalisation threshold plugin in ImageJ software 
(Fig 5.12 right column). The 2D colocalisation scatter plot shows a linear regression fit of the 
intensities of red and blue channels, in the scatter plot. The diagonal white line in the scatter plot 
is the best fit, the gradient of which is the ratio of the intensities of both channels. The 
colocalisation of nuclear DNA and NF-κB represents that NF-κB is activated upon LPS 
treatment and translocated in to the nucleus from the cytoplasm of the cell at 24 hours onwards.  
The mean Pearson Correlation Coefficient (PCC) values for control and each LPS treatment 
group are represented in the bar graph (Figure 5.13). The data represents that the localization of 
NF-κB in the nucleus significantly increased with the LPS incubation times, as compared with 
the control untreated group. Therefore, NF-κB is activated and translocated from cytoplasm to 


























Figure 5.12: Indirect immunofluorescence and confocal microscopy analysis demonstrating 
the effect of LPS infectious agents on localisation of NF-κB p65 in trophoblast cells. 
JEG-3 cells were cultured in LabTek 8-well chambers at a density of 3 x 10
3
 cells per well 
overnight in the presence of the indicated concentration of LPS (1, 10 and 20 ug/ml) for 24 hrs. 
Cells were stained with NFkB labelled with Alexa Fluor® 555 (red), cell nuclei were stained 
with 4', 6-diamidino-2-phenylindole (DAPI), which is shown in blue. Fluorochromes were 
acquired separately to evaluate the expression of NFkB using the Fiji software. 
Photomicrographs are representative of three independent experiments.  
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Figure 5.13. Quantitative analysis of colocalisation between nuclear proteins and NF-κB in 
JEG-3 cells, plotted against LPS treatment at different time points. 
JEG-3 cells treated with LPS (20 ug/ml) for 12 hrs, 24 hrs and 48 hrs. Cells were stained with 
NF-κB antibody followed by staining with FITC-conjugated goat anti-mouse antibody.     NF-κB 
expression levels were analysed by the use of Image J software. Grey bars represent expression 
of NF-κB in untreated and LPS treated JEG-3 cells. Bar graphs represent the level of nuclear 
proteins and NF-κB in mean values ± SD. Pearson Correlation Coefficient values were used to 
evaluate the colocalisation of NF-κB on JEG-3 cells. Data are representative of three 






























In this study, detection and quantification of Myoferlin on JEG-3 cell line was performed upon 
treatment with LPS. Myoferlin and VEGF quantification estimated by flow cytometry and 
confocal microscopy showed significant decrease in LPS treated JEG-3 cells in dose and time 
dependent manner. Similar observation was detected using western blot analysis. Cell 
proliferation analysis revealed a significant decrease in trophoblast cell growth in 48 hours of 
LPS treatment. NF-κB analysis following LPS treatment of JEG-3 cells revealed activation of 










This study was designed to explore the role of trophoblast in the maintenance of utero-placental 
tolerance during infection. Pregnancy involves a major involvement of both the adaptive and 
innate immune system. During pregnancy, the maternal immune system changes dramatically; it 
provides protection to the mother as well as the embryo in early stages or the fetus following 
implantation. A fundamental question not yet fully understood is whether the adaptive and innate 
recognition system changes equally during pregnancy. Several observations indicate that parts of 
the immune system are enhanced while others are suppressed. It has also been shown that 
pregnant females are susceptible to intracellular pathogens and are biased towards humoral 
rather than cell-mediated immunity. In this context, based on the pattern of cytokines released by 
the maternal immune system, it has been suggested that pregnancy is a Th2 non-inflammatory 
cytokine (e.g. interleukin-10 (IL-10), granulocyte–macrophage colony-stimulating factor (GM- 
CSF) and IL-3, in feto–placental growth, as opposed to a Th1 cytokine (e.g. interferon-γ (IFN-γ) 
and tumour necrosis factor-α (TNF-α phenomenon (Athanassakis, 2002; Wegmann et al., 1993). 
In a separate study it was shown that abortion prone women who proceed to have a successful 
pregnancy are more Th2 biased than abortion-prone women who abort. It was also shown that 
recurrent aborters who undergo spontaneous abortions have a stronger Th1 bias than aborters 
who have normal pregnancy (Makhseed et al., 2001). These studies highlight the importance of 
cytokines in pregnancy development. 
Since cytokines controlled a variety of immunological phenomenon including cell surface 
receptors involved in signalling and immune responsiveness it can be argued that the Th2 
pregnancy associated pattern of cytokines have a profound influence in immunity as a whole 




soluble factors that can prevent infections without compromising maternal immunity. 
The state of mild immunosuppression is that the Th2 pregnancy pattern implies that the mother 
undergoes a period of ‘mild immunosuppression’. This would explain that fact during pregnancy 
the mother is susceptible to otherwise benign infections from pathogens such as bacteria and 
viruses. A recent example is the outbreak of Zika virus, this pathogen can cause intrauterine 
growth restriction and spread from an infected mother to her fetus during pregnancy or at 
delivery (Larocca et al., 2016). 
Bacterial infections can on the other hand affect pregnant women from the time of fertilization, 
implantation of the fertilized ovum through the time of delivery and peri-partum period. These 
infections can also affect the development of the fetus and the new born. Bacterial infections can 
include E. coli, Group B Streptococcus, Listeria monocytogenes, Chlamydia trachomatis and 
bacterial vaginosis among others (Watt et al., 2003). Many of these infections can trigger the 
innate recognition system as a first line of protective immunity. Similar to the cells of the 
immune system like lymphocytes and macrophages, trophoblast cells can express receptors of 
innate recognition system. These receptors include pattern recognition receptors (PRR) (Shaikly 
et al., 2008). 
In this study, emphasis was placed on the pattern recognition receptors designated CD14 and 
MARCO. Their potential role in the immunology of trophoblast cells remains to be deciphered. 
Pattern recognition receptors play a primary role in innate recognition through surveillance of 
invading pathogens (Rallabhandi et al., 2006). PRR can recognise the pathogen associated 
molecular patterns (PAMPs) from pathogens such as bacteria, viruses and fungi. Upon 
recognition of PAMPs by PRR, a cascade of signalling reactions is initiated to provide the first 
line of defence to the infected host. The human placental choriocarcinoma cell line, JEG-3 was 




with syncytiotrophoblast and cytotropoblast cells of the placenta (Matsuo and Strauss, 1994; 
Hiden et al., 2007). A combination of techniques including cellular, biochemical and bioimaging 
were employed to examine expression and immunomodulation of receptors CD14, MARCO, 
Myoferlin and VEGF in response to LPS. The potential involvement of NF-κB as a non-specific 
transcriptional regulator in response to LPS was also examined. 
Intrauterine infection has been associated with preterm labour in up to 40% of cases (Lamont, 
2003). Furthermore, evidence of infection have been reported in almost 80% of preterm 
deliveries at <30 weeks of gestation (Goldenberg et al., 2000). Intrauterine infections may be 
caused by bacterial agents. In order to investigate the effect of bacterial infections on various 
cellular biological functions, bacterial endotoxin LPS have been used for in vitro studies of 
various cellular systems. Therefore, LPS was applied to the in vitro trophoblast model system to 
investigate the trophoblast responses to infection conditions. 
LPS is an important component of the outer membrane of Gram-negative bacteria which is an 
effective activator of immune responses upon bacterial infection and is likely to affect the 
maternal immune response during pregnancy (Sankala et al., 2002). In fact, Lipopolysaccharide 
(LPS) is recognised by TLR-4 and is a major cause of septic shock in intrauterine infection. 
Previous studies have reported that CD14 and MARCO receptors have a key role in the 
pathogenesis of septic shock (Oliver et al., 1999). Secretion of pro-inflammatory cytokines and 
the activation of NF-κB upon stimulation of human monocytes/ macrophages with LPS have 
been found to involve CD14 and MARCO receptors. 
In this study, surface expression of CD14 was observed on the JEG-3 cell surface. Regulation of 
CD14 in response to LPS in dose and time dependent manner revealed that CD14 expression 
increased with incubation times and with increasing concentration of LPS, where 20 µg/ml LPS 




Immunofluorescence imaging by confocal microscopy and immunoblotting analysis further 
confirmed the expression and regulation of CD14 on JEG-3 cells. The expression of CD14 and 
MARCO on JEG-3 cells haven not been previously reported. Experiments have shown that 
CD14 is one of the components of a receptor complex which mediates the LPS-induced signal 
transduction. CD14 plays a significant role in this potent immune response through the transfer 
of LPS to the TLR-4:MD2 complex (Gangloff et al., 2005). However a study with CD14- 
deficient murine macrophages has shown evidence of a CD14-independent pathway of signal 
transduction by different LPS chemotypes. The majority of Gram-negative bacteria synthesize 
‘smooth LPS’ (Gangloff et al., 2005). The smooth LPS are composed of the lipid moiety, a core 
polysaccharide and a variable O-polysaccharide whereas the failure to attach either of the 
components other than lipid A moiety results in the formation of ‘rough LPS’. In both the 
chemotypes of LPS, the lipid A moiety is the bioactive element which has pathogenic functions 
in infections caused by Gram-negative bacteria. Subsequent to induction with rough LPS, equal 
quantities of TNF was secreted by both the CD14-deficient murine macrophages and the CD14- 
expressed macrophages and no secretion of TNF to smooth LPS was observed. This signifies the 
necessity of CD14 for only the smooth LPS for the activation of TLR-4:MyD88 pathway. 
Furthermore no IFN-α/β was secreted upon stimulation with smooth or rough LPS which 
indicates that CD14 is required for TLR-4: TRIF pathway activation by both the LPS 
chemotypes. 
 (Anas et al., 2010). Therefore this suggests that the possibility of CD14 been expressed on 
trophoblast cells due its necessity for the activation of TLR-4: MyD88 and the TLR-4: TRIF 
pathway as TLR-4 is expressed on trophoblast cells and the results of this study supports this 
hypothesis (Klaffenbach et al, 2005). 
Surface expression of MARCO receptors on JEG-3 cells has been observed in this study. The 




observed that the surface expression of MARCO is down-regulated upon treatment as the 
concentration of LPS increases over time, where most significant differences were observed at 
48 hours. This was confirmed with confocal microscopy and immunoblotting results where the 
expression followed the same pattern. 
In mice, the majority of MARCO is expressed on the marginal zone macrophages in the spleen, 
on macrophages of the medullary cord in lymph nodes and on peritoneal macrophages (Granucci 
et al., 2003). The expression of human MARCO is detected to be most robust in the liver, lymph 
nodes, monocytes and alveolar macrophages which are involved in the filtration of blood and 
lymph fluids (Jozefowski et al., 2005). However the expression of MARCO on trophoblast cells 
appears to be elusive. As its expression is widely studied on monocytes it’s used as a positive 
control for our study we initially examined the expression pattern of MARCO on THP-1 which 
is a monocytic cell line. MARCO is found to have a variety of functions such as relegation of 
TLR-4 mediated responses (Mukhopadhyay et al. 2011). As the expression of MARCO appears 
to be associated with TLR-4 mediated responses which is expressed on trophoblast cells and its 
role as a major immune cell the expression pattern was examined and the results obtained of 
expression of MARCO on JEG-3 cells reinforces this hypothesis of the study. 
The effect of LPS on CD14 and MARCO on JEG-3 cells was the other key focus of this study. 
In order to investigate this effect, JEG-3 cells were stimulated with 1µg/ml, 10µg/ml and 
20µg/ml of LPS for a period of 12, 24, and 48 hours for each receptor. The interesting 
observation was that surface expression and total protein concentration detected by 
immunoblotting significantly increased for CD14 in contrary to MARCO which significantly 
decreased. MARCO has the capability of binding both Gram-positive and Gram-negative 
bacteria (Granucci et al., 2003). It has been suggested that MARCO plays a role in antimicrobial 
defence system and the up-regulation of its expression during bacterial infections in 




Thelen et al., (2010) reported that the degrees of MARCO transcription and cell surface 
expression are increased after bacterial binding which further supports its significance in 
phagocytosis of bacteria. Moreover the expression of MARCO can be stimulated upon bacterial 
infection or LPS injection as LPS present on the Gram-negative bacteria acts as a ligand of 
MARCO (Sankala et al., 2002). 
In addition to CD14 and MARCO the expression profile of Myoferlin and VEGF antigens were 
also examined on JEG-3 as well as cell proliferation following challenge with LPS. Myoferlin, 
one of the members of the Ferlin family and is a membrane protein encoded by the MYOF gene 
and found in cell membranes, nuclear membranes and cytoplasmic vesicles (Bernatchez, et al., 
2007). A high expression of myoferlin has been observed in skeletal and cardiac muscles and 
weak expression in the brain, kidney and placenta. Myoferlin is necessary for membrane 
repairing and regulation of VEGF signal transduction. There is data suggesting that successful 
implantation of the developing embryo in the maternal uterus is associated with EVT 
proliferation and invasion of the uterine wall. Decreased EVT proliferation and trophoblast cell 
death has been associated with pregnancy complications such as preeclampsia and intrauterine 
growth restriction thus resulting in inadequate trophoblast invasion (Smith et al., 1997; Allaire et 
al., 2000; Crocker et al., 2003; Kakinuma et al., 1997;). We have hypothesized that there is a 
correlation between the down-regulation of Myoferlin and the decreased cell proliferation of 
trophoblast cells upon bacterial infection. Detection of Myoferlin on JEG-3 cell line was carried 
out upon treatment of JEG-3 cells with LPS. It was observed that this treatment reduces 
Myoferlin expression. 
VEGF expression has come to light in the recent years in the context of angiogenesis and tumour 
metastasis. Both processes have a parallel with trophoblast physiology during embryonic 
development and placentation. VEGF function requires the interaction with specific receptors; in 




embryo development is unclear, although apparent lack of VEGF at the feto-maternal interface 
has been observed. Whether VEGF is modulated during bacterial infection or other factors is still 
not clear. There seems to be a scarcity of studies in this regard. It is possible that VEGF is 
modulated at different stages of pregnancy or in pregnancy abnormalities. An in vitro model was 
developed to test the effect of LPS on the expression of VEGF in JEG-3cells. Western blot 
analysis of LPS stimulated trophoblast cells revealed that as the LPS exposure time increases the 
amount of VEGF protein present decreased. Considering that the control samples gave the same 
results in each condition and the only factor that has been changed is the LPS dosage and time 
treated, it is reasonable to assume that the change in VEGF expression is a direct consequence of 
the LPS treatment. 
Previous studies have used serum of pregnant women in order to gain an understanding of 
hormone levels and detect potential abnormalities in VEGF concentrations. Evan et al. used the 
serum of women in their first trimester of normal pregnancy. They detected that VEGF serum 
concentration increases up until 10 weeks of gestation. However in pre-clamptic pregnancies, 
women had a reduced VEGF levels (Lyall et al., 1997; Reuvekamp et al., 1999). This is direct 
evidence of how VEGF can cause trophoblast dysfunction, which could result in feto-maternal 
dysfunction. A typical consequence is preeclampsia, a disorder of pregnancy characterized by 
high blood pressure. The underlying mechanism of pre-eclampsia involves abnormal formation 
of blood vessels in the placenta. VEGF is likely to be involved but its exact mechanism is not yet 
understood. Simmons et al. studies VEGF expression by immunostaining the decidua and villi 
from pre-eclamptic women; the results showed an increase in VEGF concentration (Simmons et 
al., 2000). 
In an attempt to approach the molecular basis of infections, the study was then focused on 
trophoblast cell proliferation and activation of NFκB. In this part of study, JEG-3 cell line was 




(EVT) cells for proper embryo implantation, invasion into maternal uterine wall and a successful 
pregnancy. The study results show that trophoblast JEG-3 cells' propagation is significantly 
affected in case of LPS infection, with a rapid decrease in cell proliferation. 
The data in this study shows that in JEG-3 cells, treatment of NF-κB is involved in cellular 
responses to stimuli such as stress, cytokines, bacterial or viral antigens (Gilmore, 2006). 
Incorrect regulation of NF-κB has been linked to inflammatory and autoimmune diseases, viral 
infection, septic shock, and improper immune development (Perkins, 2007). Therefore, the 
activation of NF-κB mediated by trophoblast cell infection has been investigated here. 
Microscopic data shows significant increase of translocation of NF-κB from cytoplasm to 
nucleus after 24 and 48 hours of LPS treatment. This indicates that NF-κB has been activated in 
response to LPS at 24 and 48 hours of treatment. It has been previously reported that NF-κB is 
activated in JEG-3 cells after 48 hours of LPS treatment (Lappas et al., 2006). Activation of NF- 
κB in response to treatment of. LPS ligation to TLR-4 can signal via both MyD88-dependent and 
-independent pathways (Akira and Hoshino, 2003). As a result, NF-κB can signal first trimester 
trophoblast cells to produce high levels of cytokines, includingIL-2, IL-6, TNF-α and 
IFN-γ (Abrahams et al., 2004). Trophoblast cells are highly sensitive to these cytokines, such as, 
placental expression of IFN-γ and TNF-α has been associated with trophoblast cell death 
consequence of the activation of NF-κB is the production of various pro-inflammatory 
mediators. Lipopolysaccharide induces a dose dependent increase of cytokines, interleukin (IL)- 
8 and IL-6 and a decrease in EVT invasion. (Aschkenazi et al., 2002; Yui et al., 1994). It was 
observed that LPS exposure lead to an increase in signalling pathways and phosphorylation. 
In summary, trophoblast cells are the only embryo derived cells which are present at the feto-
maternal interface and present a repertoire of selectively expressed receptors at the cell surface 
and thus function as a sensory system. Trophoblast recognises and responds to bacterial antigens 




and their quantitative modulation play a vital role in achieving immune recognition and self- 
tolerance needed for pregnancy to develop. Thus it can be suggested that trophoblast has the 


















Trophoblast cells and their membrane bound receptors and ligands function including CD14, 
MARCO and Myoferlin and VEGF act as a sensory system. Their quantitative modulation play a 
vital role in achieving the immune recognition and self-tolerance needed for pregnancy to 
develop. Furthermore, effect of bacterial agents on NF-κB activation has also been investigated. 
This data can help in future studies to investigate the TLR responses and associated signalling 
pathways involved in human pregnancy in cells isolated from normal pregnancy or patients 
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BACTERIAL LPS DIFFERENTIALLY MODULATES THE EXPRESSION OF MYOFERLIN 
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Myoferlin, one of the members of the Ferlin family is a membrane protein encoded by the 
MYOF gene and found in cell membranes, nuclear membranes and cytoplasmic vesicles. A high 
expression of myoferlin is observed in skeletal and cardiac muscles and weak expression in the 
brain, kidney and placenta. Myoferlin has been found to be necessary for membrane repairing 
and regulation of VEGF signal transduction. VEGF is not restricted to the vascular system and 
contributes to wound healing, cell division and proliferation. Successful implantation of the 
developing embryo in the maternal uterus is associated with Extravillous Trophoblast (EVT) cell 
proliferation and invasion of the uterine wall. Decreased EVT proliferation and trophoblast cell 
death has been associated with pregnancy complications such as preeclampsia and intrauterine 
growth restriction thus resulting in inadequate trophoblast invasion. We have hypothesized that 
there is a correlation between the down-regulation of Myoferlin and the decreased cell 
proliferation of trophoblast cells upon bacterial infection. In this study, detection and 
quantification of Myoferlin on JEG-3 cell line was performed upon treatment with 
Lipopolysaccharide (LPS). Proteomics quantitative data, revealed that LPS treatment induced a 
significant (p=0.0002) decrease in the expression level of Myoferlin in trophoblast cell line. 
Myoferlin quantification estimated by flow cytometry also showed significant decrease in LPS 
treated JEG-3 cells in dose dependent manner. Whereas, fluorescence microscopic imaging 
results confirmed the same. The cell proliferation assay revealed a significant decrease (62%) in 
trophoblast cell growth in 48 hours of LPS treatment. In conclusion, decreased Myoferlin 










Chemical reagents used in this study 
A. Cell culture 
Fetal bovine serum (FBS) 
Ham's F-12 with stable glutamine 
Dulbecco's Modified Eagle's Medium/ Ham's F-12 
Dimethyl sulfoxide (DMSO) 
Phosphate Buffer Saline (PBS) 
Accutase  
B. Immunofluorescent labelling 
Bovine serum albumin (BSA) 
Paraformaldehyde (PFA) 
Phosphate Buffer Saline (PBS) 
Triton-X100 




Acrylamide/bis 30% (37.5 : 1) 
Ammonium per sulphate (APS) 
Bromophenol blue 




Coo Assay reagent 
Dithiothreitol (DTT) 





Non-fat dry milk 
 Protease inhibitor cocktail 
 Protease and phosphatase inhibitors 
 Proteo-JET Cytoplasmic and Nuclear protein extraction kit 
 Polyvinylidene fluoride (PVDF) membrane 
 Sodium dodecyl sulphate (SDS) 
 Sodium thio sulphate 
 N, N, N′, N′-Tetra methyl ethylene diamine (TEMED) 
 Tris-base 
D.  Cell proliferation assay 
Fetal bovine serum (FBS) 
Phosphate Buffer Saline (PBS) 
Lipopolysaccharide (LPS) O5:B55 
Camptothecin 





A) Illustration of parameters used for colocalisation analysis. 
r (default) = 138 nm 
d (default) = 220 nm 
T 1,2 (default) = 0.3 
















B) Colocalisation analysis flow 
Screen shot of Graphical User Interface showing flow of colocalisation analysis algorithm from 
top to bottom.   







A) Sample buffer 5X (Store at -20
o
C) 
Reagents Amount in 10 ml 
0.5 M Tris HCl pH 6.8 1.2 ml 
50% Glycerol 5 ml 
10% SDS 2 ml 
1% Bromophenol blue 1 ml 
DI water 0.7 ml 
DTT 0.386 g 
 
 B) SDS-PAGE One Dimensional 
Resolving gel 12% 
Reagents Amount in 10 ml 
DI water 3.35 ml 
1.5 M Tris HCl pH 8.8  2.5 ml 
Acrylamide/bis 30% (37.5 : 1) 4.0 ml 
Ammonium persulphate (APS) 10% 50 µl 
SDS 20% 100 µl 








Stacking gel 4% 
Reagents Amount in 10 ml 
DI water 6.1 ml 
0.5 M Tris HCl pH 6.8  2.5 ml 
Acrylamide/bis 30% (37.5 : 1) 1.3 ml 
Ammonium persulphate (APS) 10% 50 µl 
SDS 20% 100 µl 
TEMED 10 µl 
 
 C) Protein extraction / Rehydration Buffer 
Recipe taken from Biorad protein extraction kit; (Catalog # 163-2087) 
Reagents Final concentration Amount in 25 ml 
Urea (FW 60.06) 7 M 10.52 g 
Thiourea (FW 76.12) 2 M 3.81 g 
CHAPS 4% w/v 0.5 g 
 
Make it up without Protease inhibitor, DTT and Ampholyte. 
Distribute into 980 µl aliquots and store at -80
o








On the day of protein extraction 
Thaw the protein extraction / rehydration buffer aliquot and follow as below; 
Reagents Final concentration Amount in 1 ml 
Protease inhibitor cocktail 
(100X) 
1X 10 µl 
DTT (FW 154.25) 20 mM 0.003g (3 mg) 
Ampholyte or IPFG buffer 1% v/v 10 µl 
Benzonase -- 1 µl 
 
The amount 1 ml of protein extraction buffer is added to 10×10
6
 cells. 
D) Bradford Assay, colorimetric method for total protein quantitation 
Bradford assay is based on the principal that when coomassie dye binds the protein in an acidic 
medium, a shift in absorption occurs from 465 nm- 595 nm resulting in a colour change from 
brown to blue. Protein standards, test samples and blank cell lysis buffer were deposited onto 
microplate wells as 5 µl aliquots. Bradford assay reagent equilibrated to room temperature, 250 
µl was added to each well. Microplate was mixed for 30 sec and incubated for 1 min at RT. 
Samples were then read at 595 nm within 15 min of preparation. Protein concentrations of the 
samples were estimated from the absorbance of the standards. All the samples and standards 








E) Stock solutions 
10X Phosphate Buffer Saline (PBS) 
NaCl  80 g 
KCl  2 g 
KH2PO4 (anhydrous)  2 g 
Na2HPO4 (anhydrous) 2 g 
Purite water  1000 ml 
1.5 M HCl pH 8.8 
27.23 g Tris-base 
80 ml  DI water 




0.5 M HCl pH 6.8 
6 g  Tris-base 
60 ml  DI water 
Add conc HCl to adjust pH 6.8 and add DI water to make final volume 100 ml. Store at 4
o
C. 
10% APS (make fresh) 
100 mg APS 





10% SDS (Store at RT) 
10 g  SDS 
100 ml DI water 
1% Bromophenol Blue 
10 ml preparation and store at room temperature (RT). 
0.1 g  Bromophenol blue 
10 ml   DI water 
10X Electrophoresis buffer/ Running Buffer 
30 g  Tris-base 
144 g  Glycine 
10 g  SDS 
1 L DI water 
Transfer buffer for western blotting  
1L preparation. Store at 4
o
C. It is used as cold and improves heat dissipation during transfer. 
Tris-base  3.03 g 
Glycine  14.4 g 
DI water  500 ml 





pH will be between 8.1 to 8.5 depending on the quality of Tris-base, methanol and DI water. 
Make the final volume 1L with DI water. 
Wash buffer (PBS-T 0.1%)  
PBS   999ml 
Tween-20  1 ml 
Store at RT. 
Blocking Buffer (Freshly made) 
Non-fat dry milk-Marvel 5 g 
PBS-T 0.1%  1 
 
 
 
 
